Clicky

Friday, November 20, 2026
All public companies · Official EDGAR

CNSYCERENOME, INC.

Nasdaq · CIK 0001095981
Filer categoryNon-accelerated filer<br>Smaller reporting company
Entity typeoperating
SIC2834 Pharmaceutical Preparations
FY end1231
XBRL facts481

Identity from submissions API

NameCERENOME, INC.
CIK0001095981
TickersCNSY
ExchangesNasdaq
Entity typeoperating
CategoryNon-accelerated filer<br>Smaller reporting company
SIC2834 Pharmaceutical Preparations
EIN330827593
LEI—
Fiscal year end1231
State of incorporationDE DE
Phone737.255.7194
Website—
Investor website—
Owner org03 Life Sciences
Flags—
Description—
Insider transactions (issuer)1
Insider transactions (owner)0

Former names

  • PLUS THERAPEUTICS, INC. (2019-02-08T05:00:00.000Z → 2026-07-01T04:00:00.000Z)
  • CYTORI THERAPEUTICS, INC. (2005-05-26T04:00:00.000Z → 2019-08-02T04:00:00.000Z)
  • MACROPORE INC (2001-07-16T04:00:00.000Z → 2005-07-05T04:00:00.000Z)
Business address
6420 LEVIT GREEN BOULEVARD
SUITE 310
HOUSTON
TX
77021
TX
Mailing address
6420 LEVIT GREEN BOULEVARD
SUITE 310
HOUSTON
TX
77021
TX

EDGAR has no company-logo API. Website field is shown when the filer provided one.

Financialist coverage

SEC filings

1468 filing rows loaded from submissions recent; extra archives: CIK0001095981-submissions-001.json (468 filings, 2001-03-30 to 2011-03-02).

FiledFormDocumentItemsAccessionFile no.FilmActSizeXBRLiXBRL
2026-11-16 8-K 8-K 8.01,9.01 0001193125-26-462116 001-34375 261555453 34 211842 1 1
2026-11-13 10-Q 10-Q 0001193125-26-460950 001-34375 261553884 34 13526906 1 1
2026-11-13 8-K 8-K 2.02,9.01 0001193125-26-460887 001-34375 261553657 34 722095 1 1
2026-11-12 4 4 0001193125-26-457094 6126
2026-11-12 8-K 8-K 5.02,8.01,9.01 0001193125-26-455816 001-34375 261541832 34 443812 1 1
2026-10-02 8-K 8-K 8.01,9.01 0001193125-26-411259 001-34375 261433419 34 13286912 1 1
2026-10-01 4 4 0001193125-26-409859 7273
2026-10-01 4 4 0001193125-26-409858 7263
2026-10-01 4 4 0001193125-26-409860 7239
2026-10-01 4 4 0001193125-26-409857 14586
2026-10-01 4 4 0001193125-26-409861 7321
2026-10-01 4 4 0001193125-26-409856 14590
2026-10-01 4 4 0001193125-26-409855 7281
2026-09-18 D xslFormDX01/primary_doc.xml 06b 0001193125-26-395734 021-598173 261391783 33 11885
2026-09-10 8-K 8-K 1.01,2.03,3.02,8.01,9.01 0001193125-26-387267 001-34375 261369675 34 2207743 1 1
2026-08-14 10-Q 10-Q 0001193125-26-352444 001-34375 261282793 34 13198730 1 1
2026-08-14 8-K 8-K 2.02,9.01 0001193125-26-352346 001-34375 261282189 34 668986 1 1
2026-08-04 8-K 8-K 5.03,9.01 0001193125-26-332939 001-34375 261239250 34 654874 1 1
2026-07-01 4 4 0001193125-26-292654 7222
2026-07-01 4 4 0001193125-26-292644 7182
2026-07-01 4 4 0001193125-26-292643 7174
2026-07-01 4 4 0001193125-26-292642 14492
2026-07-01 4 4 0001193125-26-292639 7141
2026-07-01 4 4 0001193125-26-292648 7165
2026-07-01 4 4 0001193125-26-292649 14502
2026-06-18 S-8 S-8 0001193125-26-275955 333-296907 261103214 33 378404 1 1
2026-06-05 EFFECT xslEFFECTX01/primary_doc.xml ,, 9999999995-26-001913 333-296411 261070910 33 1980
2026-06-05 8-K 8-K 1.01,9.01 0001193125-26-259703 001-34375 261069579 34 176058 1 1
2026-06-05 CORRESP filename1.htm 0001193125-26-258709 6061
2026-06-05 S-3/A S-3/A 0001193125-26-258388 333-296411 261066860 33 436752
2026-06-04 UPLOAD filename1.pdf 0000000000-26-005651 333-296411 146086
2026-06-02 S-3 S-3 0001193125-26-252119 333-296411 261053300 33 1032223
2026-05-18 4 4 0001193125-26-228933 8111
2026-05-18 4 4 0001193125-26-228930 8101
2026-05-18 4 4 0001193125-26-228929 8119
2026-05-18 4 4 0001193125-26-228926 8077
2026-05-18 4 4 0001193125-26-228922 10309
2026-05-18 4 4 0001193125-26-228919 8085
2026-05-18 4 4 0001193125-26-228917 8072
2026-05-15 8-K 8-K 5.07 0001193125-26-227059 001-34375 26989123 34 226015 1 1
2026-05-15 10-Q 10-Q 0001193125-26-226978 001-34375 26988661 34 8981788 1 1
2026-05-15 8-K 8-K 2.02,9.01 0001193125-26-226747 001-34375 26987544 34 573979 1 1
2026-05-15 SCHEDULE 13G/A xslSCHEDULE_13G_X02/primary_doc.xml 0001649553-26-000057 005-80327 26984761 34 12108
2026-05-15 SCHEDULE 13G xslSCHEDULE_13G_X02/primary_doc.xml 0000919574-26-003205 005-80327 26982065 34 9713
2026-04-22 4 4 0001193125-26-170730 8015
2026-04-21 3 3 0001193125-26-167116 3975
2026-04-21 8-K 8-K 8.01,9.01 0001193125-26-165205 001-34375 26876807 34 175812 1 1
2026-04-09 8-K 8-K 5.02,9.01 0001193125-26-148920 001-34375 26849860 34 296301 1 1
2026-04-08 8-K 8-K 8.01,9.01 0001193125-26-146335 001-34375 26846518 34 196440 1 1
2026-04-02 8-K 8-K 3.03,5.03,8.01,9.01 0001193125-26-140267 001-34375 26834219 34 224270 1 1
2026-04-01 4 4 0001193125-26-135711 10886
2026-04-01 4 4 0001193125-26-135710 10892
2026-03-31 DEFA14A DEFA14A 0001140361-26-012353 001-34375 26822454 34 530714
2026-03-31 ARS ARS 0001193125-26-134670 001-34375 26822322 34 3995446
2026-03-31 DEF 14A DEF 14A 0001193125-26-134646 001-34375 26822214 34 5760239 1 1
2026-03-30 3 3 0001193125-26-132171 3947
2026-03-26 8-K 8-K 5.02 0001193125-26-125195 001-34375 26794474 34 167054 1 1
2026-03-12 8-K 8-K 5.08,8.01 0001193125-26-104291 001-34375 26748389 34 163987 1 1
2026-03-12 10-K 10-K 0001193125-26-104258 001-34375 26748228 34 14890993 1 1
2026-03-12 8-K 8-K 2.02,9.01 0001193125-26-104218 001-34375 26748072 34 596011 1 1
2026-03-06 RW RW 0001193125-26-096495 333-280061 26730867 NE 7570
2026-02-27 4 4 0001193125-26-082607 7960
2026-02-27 4 4 0001193125-26-082584 7947
2026-02-13 8-K 8-K 5.02 0001193125-26-051379 001-34375 26632813 34 250257 1 1
2026-01-22 SCHEDULE 13G xslSCHEDULE_13G_X01/primary_doc.xml 0001649553-26-000002 005-80327 26550008 34 15483
2026-01-22 8-K 8-K 8.01,9.01 0001193125-26-018675 001-34375 26549688 34 12536200 1 1
2026-01-16 8-K 8-K 1.01,8.01,9.01 0001193125-26-015346 001-34375 26539465 34 433848 1 1
2026-01-14 424B4 424B4 0001193125-26-012905 333-292637 26533303 33 2042107
2026-01-13 EFFECT xslEFFECTX01/primary_doc.xml ,, 9999999995-26-000164 333-292637 26531391 33 1979
2026-01-13 S-1MEF S-1MEF 0001193125-26-012091 333-292717 26531369 33 317727 1 1
2026-01-09 CORRESP filename1.htm 0001193125-26-009092 5419
2026-01-09 CORRESP filename1.htm 0001193125-26-009088 6890
2026-01-09 S-1 S-1 0001193125-26-008922 333-292637 26523199 33 13915652 1 1
2026-01-02 4 4 0001193125-26-000967 7131
2026-01-02 4 4 0001193125-26-000966 7129
2025-11-25 DRS filename1.htm 0001193125-25-294028 377-08727 251514725 33 396761
2025-11-17 8-K 8-K 7.01,8.01,9.01 0001193125-25-283935 001-34375 251489336 34 154916 1 1
2025-11-05 4 4 0001193125-25-265866 5181
2025-10-30 10-Q 10-Q 0001193125-25-258596 001-34375 251435935 34 10500313 1 1
2025-10-30 8-K 8-K 2.02,9.01 0001193125-25-258568 001-34375 251435753 34 628265 1 1
2025-10-21 8-K 8-K 1.01,2.03,9.01 0001193125-25-244275 001-34375 251405360 34 1253623 1 1
2025-10-03 4 4 0001193125-25-230296 7128
2025-10-03 4/A 4/A 0001193125-25-230292 8014
2025-10-03 4 4 0001193125-25-230291 7125
2025-10-03 4/A 4/A 0001193125-25-230288 8012
2025-08-26 8-K 8-K 8.01 0001193125-25-188075 001-34375 251252571 34 143014 1 1
2025-08-25 4 4 0000950170-25-111092 4570
2025-08-22 S-8 S-8 0001193125-25-186490 333-289822 251247264 33 290844 1 1
2025-08-15 4 4 0000950170-25-109414 7770
2025-08-15 4 4 0000950170-25-109413 7824
2025-08-15 4 4 0000950170-25-109412 5593
2025-08-15 4 4 0000950170-25-109411 5569
2025-08-15 4 4 0000950170-25-109410 5617
2025-08-15 4 4 0000950170-25-109409 7822
2025-08-15 4 4 0000950170-25-109408 5603
2025-08-15 424B3 424B3 0001193125-25-181897 333-289526 251225025 33 259877
2025-08-15 3 3 0000950170-25-109401 3767
2025-08-14 EFFECT xslEFFECTX01/primary_doc.xml ,, 9999999995-25-002625 333-289526 251222297 33 1980
2025-08-14 SCHEDULE 13G/A xslSCHEDULE_13G_X01/primary_doc.xml 0001079973-25-001307 005-80327 251221739 34 7877
2025-08-14 8-K 8-K 8.01,9.01 0001193125-25-180814 001-34375 251219806 34 173620 1 1
2025-08-14 10-Q 10-Q 0000950170-25-108874 001-34375 251219149 34 10123907 1 1
2025-08-14 8-K 8-K 2.02,9.01 0000950170-25-108854 001-34375 251218883 34 638297 1 1
2025-08-13 8-K 8-K 8.01 0001193125-25-179382 001-34375 251208798 34 137505 1 1
2025-08-12 CORRESP filename1.htm 0001193125-25-179175 6020
2025-08-12 8-K 8-K 5.07 0001193125-25-179012 001-34375 251207246 34 154227 1 1
2025-08-12 S-1 S-1 0001193125-25-178940 333-289526 251206652 33 645104 1 1
2025-08-05 UPLOAD filename1.pdf 0000000000-25-008211 377-08286 40505
2025-08-04 DRS filename1.htm 0000950123-25-006916 377-08286 251177780 33 439745
2025-08-01 DEFA14A DEFA14A 0001140361-25-028381 001-34375 251176244 34 76668
2025-07-29 SCHEDULE 13G/A xslSCHEDULE_13G_X01/primary_doc.xml 0001641172-25-021367 005-80327 251161810 34 9607
2025-07-25 RW RW 0001193125-25-165419 333-282507 251151619 NE 7363
2025-07-21 ARS ARS 0001140361-25-026612 001-34375 251137355 34 3840515
2025-07-21 DEF 14A DEF 14A 0001140361-25-026611 001-34375 251137322 34 6719420 1 1
2025-07-18 8-K 8-K 4.01,9.01 0001193125-25-161239 001-34375 251134847 34 146545 1 1
2025-07-11 PRE 14A PRE 14A 0001140361-25-025650 001-34375 251119077 34 6707550 1 1
2025-06-25 SCHEDULE 13G/A xslSCHEDULE_13G_X01/primary_doc.xml 0001213900-25-057808 005-80327 251073864 34 6778
2025-06-23 EFFECT xslEFFECTX01/primary_doc.xml ,, 9999999995-25-002000 333-288121 251066536 33 1980
2025-06-23 RW RW 0001193125-25-144654 333-286393 251065118 NE 7280
2025-06-23 424B3 424B3 0001193125-25-144289 333-288121 251063158 33 258036
2025-06-20 8-K 8-K 1.01,3.02,9.01 0001193125-25-143665 001-34375 251061575 34 579599 1 1
2025-06-20 S-1/A S-1/A 0001193125-25-142935 333-288121 251058867 33 400049
2025-06-18 S-1 S-1 0001193125-25-142215 333-288121 251054973 33 780139
2025-06-17 CORRESP filename1.htm 0001193125-25-142216 6908
2025-06-17 8-K 8-K 1.01,3.03,9.01 0001193125-25-142093 001-34375 251053636 34 314563 1 1
2025-06-13 UPLOAD filename1.pdf 0000000000-25-006276 377-08090 40538
2025-06-09 DRS filename1.htm 0000950123-25-005986 377-08090 251035081 33 402509
2025-06-06 8-K 8-K 3.01 0001193125-25-137089 001-34375 251031012 34 143925 1 1
2025-05-30 8-K 8-K 2.02,9.01 0000950170-25-079749 001-34375 251011254 34 532709 1 1
2025-05-30 10-Q 10-Q 0000950170-25-079738 001-34375 251011110 34 7515663 1 1
2025-05-23 8-K 8-K 3.01,7.01,9.01 0001193125-25-125860 001-34375 25982625 34 152648 1 1
2025-05-22 SCHEDULE 13G xslSCHEDULE_13G_X01/primary_doc.xml 0001213900-25-046800 005-80327 25976674 34 6873
2025-05-19 8-K 8-K 3.01 0000950170-25-074374 001-34375 25964207 34 165387 1 1
2025-05-15 NT 10-Q NT 10-Q 0000950170-25-072596 001-34375 25952686 34 70046
2025-05-07 144 xsl144X01/primary_doc.xml 0001972490-25-000004 001-34375 25920177 33 7050
2025-05-02 8-K 8-K 5.03,5.07,8.01,9.01 0000950170-25-062742 001-34375 25908400 34 227384 1 1
2025-05-01 DEFA14A DEFA14A 0000950170-25-061484 001-34375 25900146 34 87456
2025-04-30 10-K/A 10-K/A 0000950170-25-061028 001-34375 25894896 34 2982496 1 1
2025-04-23 S-3/A S-3/A 0001193125-25-091456 333-286393 25862269 33 322908
2025-04-18 424B3 424B3 0000950170-25-055884 333-280061 25850682 33 61778
2025-04-18 8-K 8-K 5.02 0000950170-25-055883 001-34375 25850663 34 167895 1 1
2025-04-11 POS AM POS AM 0001193125-25-079109 333-280061 25832200 33 297165
2025-04-11 UPLOAD filename1.pdf 0000000000-25-003866 001-34375 39936
2025-04-10 DEF 14A DEF 14A 0001140361-25-013256 001-34375 25828524 34 2717221
2025-04-04 S-3 S-3 0001193125-25-073481 333-286393 25815423 33 343497
2025-04-01 CORRESP filename1.htm 0001193125-25-070569 15799
2025-04-01 PRER14A ny20044910x2_prer14a.htm 0001140361-25-011649 001-34375 25801093 34 2549906
2025-03-31 10-K 10-K 0000950170-25-047698 001-34375 25793197 34 11379057 1 1
2025-03-31 RW RW 0001140361-25-011284 333-275712 25793027 NE 7167
2025-03-27 8-K 8-K 2.02,9.01 0000950170-25-046110 001-34375 25779712 34 535584 1 1
2025-03-24 UPLOAD filename1.pdf 0000000000-25-003134 001-34375 46019
2025-03-18 SCHEDULE 13G xslSCHEDULE_13G_X01/primary_doc.xml 0001079973-25-000412 005-80327 25748590 34 7828
2025-03-14 PRE 14A PRE 14A 0001140361-25-008857 001-34375 25741362 34 2430928
2025-03-10 424B3 424B3 0001193125-25-050395 333-280061 25722157 33 32301
2025-03-10 8-K 8-K 8.01 0001193125-25-050390 001-34375 25722150 34 154733 1 1
2025-03-04 424B3 424B3 0001193125-25-045309 333-280061 25703166 33 767159
2025-03-04 8-K 8-K 1.01,3.02,9.01 0001193125-25-045305 001-34375 25703151 34 1095889 1 1
2025-02-20 4 4 0000950170-25-024344 5597
2025-02-20 4 4 0000950170-25-024343 5573
2025-02-20 4 4 0000950170-25-024342 5621
2025-02-20 4 4 0000950170-25-024337 5455
2025-02-20 4 4 0000950170-25-024341 5607
2025-02-20 4 4 0000950170-25-024340 5457
2025-02-20 4 4 0000950170-25-024339 5594
2025-02-18 424B3 424B3 0001193125-25-028154 333-280061 25632745 33 1109939
2025-02-18 8-K 8-K 1.01,2.03,3.02,7.01,9.01 0001193125-25-028151 001-34375 25632740 34 1529468 1 1
2025-02-10 SCHEDULE 13G/A xslSCHEDULE_13G_X01/primary_doc.xml 0001493152-25-005541 005-80327 25603742 34 9782
2024-11-14 8-K 8-K 2.02,9.01 0000950170-24-127067 001-34375 241462318 34 491179 1 1
2024-11-14 424B3 424B3 0000950170-24-127065 333-280061 241462277 33 1485739
2024-11-14 10-Q 10-Q 0000950170-24-127014 001-34375 241461555 34 6726662 1 1
2024-11-01 424B3 424B3 0001193125-24-249276 333-280061 241417158 33 26893
2024-11-01 8-K 8-K 8.01 0001193125-24-249270 001-34375 241417148 34 144677 1 1
2024-10-04 S-3 S-3 0001193125-24-233052 333-282507 241355030 33 848771
2024-09-17 4 4 0000950170-24-107008 5092
2024-09-16 4 4 0000950170-24-106605 5093
2024-09-13 4 4 0000950170-24-106180 4546
2024-09-13 4 4 0000950170-24-106179 4526
2024-09-12 4 4 0000950170-24-105961 5677
2024-09-12 4 4 0000950170-24-105960 5663
2024-09-12 4 4 0000950170-24-105959 5653
2024-09-12 4 4 0000950170-24-105958 5629
2024-09-12 4 4 0000950170-24-105957 5650
2024-09-12 4 4 0000950170-24-105956 5562
2024-09-12 4 4 0000950170-24-105954 5564
2024-09-11 4 4 0000950170-24-105331 5178
2024-09-11 4 4 0000950170-24-105330 4633
2024-09-06 424B3 424B3 0001193125-24-215225 333-280061 241285066 33 27797
2024-09-06 8-K 8-K 3.01 0001193125-24-215218 001-34375 241285040 34 146007 1 1
2024-08-23 S-8 S-8 0001193125-24-206212 333-281758 241236726 33 218175
2024-08-15 424B3 424B3 0001193125-24-201376 333-280061 241213183 33 47027
2024-08-15 8-K 8-K 5.07 0001193125-24-201372 001-34375 241213151 34 162662 1 1
2024-08-14 424B3 424B3 0000950170-24-097130 333-280061 241209059 33 1336210
2024-08-14 10-Q 10-Q 0000950170-24-097091 001-34375 241208642 34 6873832 1 1
2024-08-14 8-K 8-K 2.02,9.01 0000950170-24-097001 001-34375 241207689 34 500078 1 1
2024-07-12 DEFA14A DEFA 14A 0001140361-24-033065 001-34375 241114973 34 1443457
2024-07-10 ARS ARS 0001140361-24-032810 001-34375 241109305 34 2523263
2024-07-10 DEF 14A DEF 14A 0001140361-24-032783 001-34375 241108663 34 3813988
2024-06-24 EFFECT xslEFFECTX01/primary_doc.xml S-1,,2024-06-24 17:00:00 9999999995-24-001930 333-280061 241066068 33 1987
2024-06-24 424B3 424B3 0001193125-24-167044 333-280061 241065258 33 1436552
2024-06-24 S-1/A S-1/A 0001193125-24-166942 333-280061 241064369 33 1573865
2024-06-20 CORRESP filename1.htm 0001193125-24-164446 7567
2024-06-14 UPLOAD filename1.pdf 0000000000-24-006829 333-280061 40533
2024-06-07 S-1 S-1 0001193125-24-157500 333-280061 241030507 33 8799645 1 1
2024-06-07 8-K 8-K 5.02 0000950170-24-070569 001-34375 241029184 34 162641 1 1
2024-06-05 SC 13G formsc13g.htm 0001493152-24-022638 005-80327 241020727 34 91692
2024-06-04 8-K 8-K 1.01,1.02,2.03,9.01 0001193125-24-154380 001-34375 241019407 34 382559 1 1
2024-05-20 8-K 8-K 5.08,8.01 0000950170-24-062116 001-34375 24962319 34 165597 1 1
2024-05-15 8-K 8-K 2.02,9.01 0000950170-24-060399 001-34375 24950166 34 438115 1 1
2024-05-15 10-Q 10-Q 0000950170-24-060395 001-34375 24950080 34 5144679 1 1
2024-05-10 4 4 0000950170-24-057456 7235
2024-05-10 4 4 0000950170-24-057455 7241
2024-05-10 4 4 0000950170-24-057454 7153
2024-05-10 4 4 0000950170-24-057452 7129
2024-05-10 4 4 0000950170-24-057453 7149
2024-05-10 4 4 0000950170-24-057451 7174
2024-05-09 8-K 8-K 1.01,3.02,9.01 0001193125-24-135399 001-34375 24931972 34 1004502 1 1
2024-03-14 8-K 8-K 3.01 0001193125-24-068002 001-34375 24751136 34 145919 1 1
2024-03-13 8-K 8-K 7.01,9.01 0001193125-24-066407 001-34375 24744615 34 13128203 1 1
2024-03-08 S-1/A S-1/A 0001193125-24-063694 333-275712 24734869 33 445228
2024-03-05 8-K 8-K 2.02,9.01 0000950170-24-025866 001-34375 24720214 34 410705 1 1
2024-03-05 10-K 10-K 0000950170-24-025851 001-34375 24720166 34 9172720 1 1
2024-02-26 4 4 0000950170-24-020419 5628
2024-02-26 4 4 0000950170-24-020418 5577
2024-02-26 4 4 0000950170-24-020417 5560
2024-02-26 4 4 0000950170-24-020416 5561
2024-02-26 4 4 0000950170-24-020415 5676
2024-02-26 4 4 0000950170-24-020414 5662
2024-02-26 4 4 0000950170-24-020412 5652
2024-02-26 4 4 0000950170-24-020411 5649
2023-12-15 4 FORM 4 SUBMISSION 0001209191-23-058816 5486
2023-11-22 424B3 424B3 0001193125-23-282261 333-275531 231433780 33 397537
2023-11-22 S-1 S-1 0001193125-23-282240 333-275712 231433480 33 427640
2023-11-20 EFFECT xslEFFECTX01/primary_doc.xml S-1,,2023-11-20 09:00:00 9999999995-23-003400 333-275531 231424379 33 1915
2023-11-20 8-K 8-K 7.01,8.01,9.01 0001193125-23-280212 001-34375 231420694 34 177154 1 1
2023-11-17 CORRESP filename1.htm 0001193125-23-279631 6741
2023-11-17 UPLOAD filename1.pdf 0000000000-23-012632 40489
2023-11-17 4 FORM 4 SUBMISSION 0001209191-23-055638 6246
2023-11-15 4 FORM 4 SUBMISSION 0001209191-23-055264 7309
2023-11-14 S-1 S-1 0001193125-23-276323 333-275531 231401071 33 537239
2023-11-13 4 FORM 4 SUBMISSION 0001209191-23-054914 7309
2023-11-08 4 FORM 4 SUBMISSION 0001209191-23-054650 6778
2023-10-31 8-K 8-K 8.01 0001193125-23-267279 001-34375 231365420 34 143144 1 1
2023-10-31 8-K 8-K 2.02,9.01 0001193125-23-267200 001-34375 231364576 34 261341 1 1
2023-10-31 10-Q 10-Q 0000950170-23-056844 001-34375 231364490 34 6017966 1 1
2023-09-15 4 FORM 4 SUBMISSION 0001209191-23-049535 4677
2023-09-12 4 FORM 4 SUBMISSION 0001209191-23-049058 4699
2023-08-21 424B3 424B3 0001193125-23-216390 333-273823 231187186 33 309765
2023-08-18 EFFECT xslEFFECTX01/primary_doc.xml S-1,,2023-08-18 17:00:00 9999999995-23-002444 333-273823 231187166 33 1915
2023-08-16 CORRESP filename1.htm 0001193125-23-214464 7325
2023-08-16 UPLOAD filename1.pdf 0000000000-23-008963 40495
2023-08-14 8-K 8-K 2.02,9.01 0000950170-23-042421 001-34375 231170248 34 655776 1 1
2023-08-14 10-Q 10-Q 0000950170-23-042363 001-34375 231169607 34 5760219 1 1
2023-08-09 S-1 S-1 0001193125-23-206816 333-273823 231153416 33 452515
2023-06-08 4 FORM 4 SUBMISSION 0001209191-23-035267 4674
2023-05-16 8-K 8-K 8.01,9.01 0001193125-23-145665 001-34375 23925631 34 151010 1 1
2023-05-04 4 FORM 4 SUBMISSION 0001209191-23-027213 4675
2023-04-28 8-K 8-K 3.03,5.03,5.07,8.01,9.01 0001193125-23-127227 001-34375 23867179 34 187182 1 1
2023-04-21 8-K 8-K 5.07,9.01 0000950170-23-013745 001-34375 23834442 34 699132 1 1
2023-04-20 8-K 8-K 2.02,9.01 0000950170-23-013672 001-34375 23833116 34 609198 1 1
2023-04-20 10-Q 10-Q 0000950170-23-013671 001-34375 23833097 34 5590634 1 1
2023-03-13 8-K 8-K 7.01 0000950170-23-007414 001-34375 23725629 34 165105 1 1
2023-03-07 DEF 14A DEF 14A 0001193125-23-063024 001-34375 23713212 34 1100021
2023-03-06 4 FORM 4 SUBMISSION 0001209191-23-016526 4671
2023-03-03 8-K 8-K 1.01,3.02,3.03,5.03,9.01 0001193125-23-060090 001-34375 23704621 34 217694 1 1
2023-02-24 PRE 14A PRE 14A 0001193125-23-048931 001-34375 23668499 34 1595775
2023-02-23 8-K 8-K 2.02,9.01 0000950170-23-004104 001-34375 23659734 34 638948 1 1
2023-02-23 10-K 10-K 0000950170-23-004099 001-34375 23659665 34 9527704 1 1
2023-02-17 4 FORM 4 SUBMISSION 0001209191-23-010651 5546
2023-02-17 4 FORM 4 SUBMISSION 0001209191-23-010652 5746
2023-02-17 4 FORM 4 SUBMISSION 0001209191-23-010639 5756
2023-02-17 4 FORM 4 SUBMISSION 0001209191-23-010638 5562
2023-02-17 4 FORM 4 SUBMISSION 0001209191-23-010640 5743
2023-02-17 4 FORM 4 SUBMISSION 0001209191-23-010637 5722
2023-02-17 4 FORM 4 SUBMISSION 0001209191-23-010636 5546
2023-02-13 SC 13G/A d9929592_13g-a.htm 0000919574-23-001079 005-80327 23617623 34 134973
2023-01-04 4 FORM 4 SUBMISSION 0001209191-23-001447 5220
2022-12-15 8-K 8-K 8.01 0001193125-22-305927 001-34375 221465144 34 142449 1 1
2022-11-28 8-K 8-K 3.01 0001193125-22-293409 001-34375 221425633 34 147118 1 1
2022-10-20 8-K 8-K 2.02,9.01 0000950170-22-019805 001-34375 221321497 34 685451 1 1
2022-10-20 10-Q 10-Q 0000950170-22-019798 001-34375 221321343 34 6223377 1 1
2022-09-22 8-K 8-K 1.01,7.01,9.01 0001193125-22-248711 001-34375 221257817 34 439812 1 1
2022-09-09 8-K 8-K 1.01,9.01 0001193125-22-242028 001-34375 221236620 34 390736 1 1
2022-09-09 424B5 424B5 0001193125-22-242025 333-249410 221236612 33 386358
2022-08-18 424B3 424B3 0001193125-22-223420 333-266684 221176018 33 308525
2022-08-17 EFFECT xslEFFECTX01/primary_doc.xml S-1,,2022-08-17 16:00:00 9999999995-22-002419 333-266684 221176232 33 1915
2022-08-17 8-K FORM 8-K 8.01 0001193125-22-223362 001-34375 221175397 34 144374 1 1
2022-08-15 CORRESP filename1.htm 0001193125-22-221204 6649
2022-08-15 UPLOAD filename1.pdf 0000000000-22-008659 40346
2022-08-09 S-1 S-1 0001193125-22-215328 333-266684 221146178 33 449515
2022-08-08 8-K 8-K 1.01,1.02,3.02,9.01 0001193125-22-215050 001-34375 221145391 34 569849 1 1
2022-07-21 8-K 8-K 2.02,9.01 0001564590-22-026158 001-34375 221097164 34 575635 1 1
2022-07-21 10-Q 10-Q 0001564590-22-026156 001-34375 221097147 34 4817959 1 1
2022-06-16 4 FORM 4 SUBMISSION 0001209191-22-037240 4754
2022-06-06 4 FORM 4 SUBMISSION 0001209191-22-034420 4645
2022-05-27 8-K 8-K 3.01 0001193125-22-162350 001-34375 22977582 34 144549 1 1
2022-05-20 8-K 8-K_ANNUAL_MEETING 5.07,9.01 0001564590-22-020874 001-34375 22947491 34 538882 1 1
2022-05-19 4 FORM 4 SUBMISSION 0001209191-22-030494 4664
2022-04-28 4 FORM 4 SUBMISSION 0001209191-22-025901 5282
2022-04-27 4 FORM 4 SUBMISSION 0001209191-22-025719 4750
2022-04-27 4 FORM 4 SUBMISSION 0001209191-22-025718 5290
2022-04-21 8-K Q1 2022 PR 8-K 2.02,9.01 0001564590-22-015078 001-34375 22841512 34 534029 1 1
2022-04-21 10-Q 10-Q 0001564590-22-015075 001-34375 22841449 34 5844016 1 1
2022-04-07 DEFA14A DEFA14A 0001564590-22-013882 001-34375 22814642 34 1723778
2022-04-07 DEF 14A DEF 14A 0001564590-22-013877 001-34375 22814546 34 3037662
2022-04-05 8-K 8-K MEDIDATA MATERIAL AGREEMENT 1.01,7.01,9.01 0001564590-22-013497 001-34375 22805165 34 190005 1 1
2022-03-28 4/A FORM 4/A SUBMISSION 0000899243-22-012518 5822
2022-03-28 PRE 14A PRE 14A 0001564590-22-011988 001-34375 22775832 34 3040110
2022-03-03 4 FORM 4 SUBMISSION 0001209191-22-015201 5276
2022-02-24 8-K 8-K 2.02,9.01 0001564590-22-006711 001-34375 22671166 34 547368 1 1
2022-02-24 10-K 10-K 0001564590-22-006708 001-34375 22671115 34 9884935 1 1
2022-02-11 SC 13G/A AMENDMENT NO. 3 TO SCHEDULE 13G 0001213900-22-006707 005-80327 22616781 34 50860
2022-02-04 SC 13G d9172057_13-g.htm 0000919574-22-000666 005-80327 22594309 34 137237
2022-02-04 SC 13G/A PSTV 13G/A 0001393825-22-000105 005-80327 22593327 34 55831
2022-01-14 8-K 8-K 1.01,9.01 0001193125-22-009885 001-34375 22532087 34 378547 1 1
2022-01-14 424B5 424B5 0001193125-22-009876 333-249410 22532045 33 370073
2022-01-06 8-K 8-K 1.01,7.01,9.01 0001193125-22-003142 001-34375 22513631 34 169839 1 1
2021-11-24 4 FORM 4 SUBMISSION 0000899243-21-046120 5633
2021-11-24 3 FORM 3 SUBMISSION 0000899243-21-046119 7686
2021-11-18 8-K 8-K 7.01,8.01,9.01 0001193125-21-333232 001-34375 211422654 34 180279 1 1
2021-11-04 4 FORM 4 SUBMISSION 0001209191-21-062868 4751
2021-10-28 4 FORM 4 SUBMISSION 0001209191-21-061858 4669
2021-10-27 4 FORM 4 SUBMISSION 0001209191-21-061724 4759
2021-10-27 4 FORM 4 SUBMISSION 0001209191-21-061723 4751
2021-10-21 8-K 8-K 2.02,9.01 0001564590-21-051444 001-34375 211337194 34 610626 1 1
2021-10-21 10-Q 10-Q 0001564590-21-051432 001-34375 211337085 34 5991815 1 1
2021-09-21 8-K 8-K 3.03,5.03,9.01 0001193125-21-277718 001-34375 211264777 34 357314 1 1
2021-09-15 4 FORM 4 SUBMISSION 0001209191-21-056096 5234
2021-09-13 8-K 8-K 5.02,7.01,9.01 0001193125-21-270847 001-34375 211248605 34 248177 1 1
2021-09-10 EFFECT xslEFFECTX01/primary_doc.xml S-1,,2021-09-10 17:00:00 9999999995-21-003481 333-259325 211248442 33 1915
2021-09-10 424B3 424B3 0001193125-21-270128 333-259325 211247765 33 370956
2021-09-08 CORRESP filename1.htm 0001193125-21-267955 7400
2021-09-08 UPLOAD filename1.pdf 0000000000-21-010922 40247
2021-09-03 S-1 S-1 0001193125-21-265606 333-259325 211237198 33 498217
2021-07-29 4 FORM 4 SUBMISSION 0001209191-21-048660 6273
2021-07-22 10-Q 10-Q 0001564590-21-037601 001-34375 211107797 34 5517001 1 1
2021-07-22 8-K Q2 2021 PR 2.02,9.01 0001564590-21-037592 001-34375 211107658 34 448286
2021-07-06 10-Q/A 10-Q/A 0001564590-21-035799 001-34375 211072486 34 119771
2021-06-11 4 FORM 4 SUBMISSION 0001209191-21-040096 8012
2021-05-27 4 FORM 4 SUBMISSION 0001209191-21-036243 5546
2021-05-27 4 FORM 4 SUBMISSION 0001209191-21-036242 5753
2021-05-27 4 FORM 4 SUBMISSION 0001209191-21-036241 5546
2021-05-27 4 FORM 4 SUBMISSION 0001209191-21-036240 5767
2021-05-27 4 FORM 4 SUBMISSION 0001209191-21-036238 5740
2021-05-27 4 FORM 4 SUBMISSION 0001209191-21-036237 5719
2021-05-20 8-K 8-K 5.07,9.01 0001193125-21-167126 001-34375 21942271 34 218078
2021-05-03 4 FORM 4 SUBMISSION 0001209191-21-029409 4758
2021-04-22 8-K Q1 2021 PR 2.02,9.01 0001564590-21-020106 001-34375 21844904 34 365112
2021-04-22 10-Q 10-Q 0001564590-21-020103 001-34375 21844812 34 4331999 1
2021-04-05 DEFA14A DEFA14A 0001193125-21-106467 001-34375 21806414 34 602595
2021-04-05 DEF 14A DEF 14A 0001193125-21-106460 001-34375 21806358 34 1157069
2021-03-12 424B3 424B3 0001193125-21-079663 333-253612 21737574 33 366364
2021-03-09 EFFECT xslEFFECTX01/primary_doc.xml S-1,,2021-03-09 16:00:00 9999999995-21-000882 333-253612 21728153 33 1914
2021-03-05 CORRESP filename1.htm 0001193125-21-071468 7828
2021-03-05 4 FORM 4 SUBMISSION 0001209191-21-018052 4756
2021-03-04 UPLOAD filename1.pdf 0000000000-21-002621 40371
2021-03-04 4 FORM 4 SUBMISSION 0001209191-21-017597 4645
2021-02-26 S-1 S-1 0001193125-21-060556 333-253612 21689371 33 489430
2021-02-26 10-K/A 10-K/A 0001193125-21-060369 001-34375 21688731 34 266669
2021-02-26 SC 13G/A SC 13G/A 0001019056-21-000168 005-80327 21686209 34 93934
2021-02-26 SC 13G/A SC 13G/A 0001019056-21-000166 005-80327 21684481 34 92440
2021-02-23 424B5 424B5 0001193125-21-052410 333-249410 21665897 33 345278
2021-02-23 8-K 8-K 8.01,9.01 0001193125-21-052325 001-34375 21665388 34 26639
2021-02-22 8-K 8-K 2.02,9.01 0001564590-21-007172 001-34375 21660699 34 507708
2021-02-22 10-K 10-K 0001564590-21-007165 001-34375 21660429 34 10176900 1
2021-02-18 4 FORM 4 SUBMISSION 0001209191-21-011788 5546
2021-02-18 4 FORM 4 SUBMISSION 0001209191-21-011787 5543
2021-02-10 SC 13G/A PSTV 13GA 0001393825-21-000058 005-80327 21613441 34 57518
2021-01-29 SC 13G/A AMENDMENT NO. 2 TO SCHEDULE 13G 0001213900-21-005149 005-80327 21568047 34 57501
2021-01-12 8-K 8-K 1.01 0001564590-21-000914 001-34375 21522341 34 23759
2020-12-14 4 FORM 4 SUBMISSION 0001209191-20-063108 5291
2020-12-02 4 FORM 4 SUBMISSION 0001209191-20-061011 5291
2020-11-06 424B3 424B3 0001193125-20-288035 333-249728 201295048 33 323477
2020-11-05 EFFECT xslEFFECTX01/primary_doc.xml S-1,,2020-11-05 17:00:00 9999999995-20-003092 333-249728 201292257 33 1915
2020-11-03 CORRESP filename1.htm 0001564590-20-050154 14402
2020-11-03 UPLOAD filename1.pdf 0000000000-20-010403 40415
2020-10-29 S-1 S-1 0001193125-20-281074 333-249728 201273004 33 436557
2020-10-23 424B5 424B5 0001193125-20-275581 333-249410 201258425 33 352694
2020-10-23 8-K 8-K 1.01,9.01 0001193125-20-275474 001-34375 201257885 34 199933
2020-10-22 8-K 8-K 2.02,9.01 0001564590-20-047276 001-34375 201255080 34 577843
2020-10-22 10-Q 10-Q 0001564590-20-047266 001-34375 201255001 34 6430684 1
2020-10-19 EFFECT xslEFFECTX01/primary_doc.xml S-3,,2020-10-19 17:00:00 9999999995-20-002910 333-249410 201247252 33 1915
2020-10-15 CORRESP filename1.htm 0001564590-20-046576 14402
2020-10-15 UPLOAD filename1.pdf 0000000000-20-009755 40459
2020-10-09 S-3 S-3 0001564590-20-046208 333-249410 201233312 33 1020760
2020-10-06 8-K 2020 LPC 1.01,3.02,9.01 0001564590-20-045846 001-34375 201225539 34 468075
2020-10-05 8-K 8-K UNDERWRITER WARRANT AMENDMENT 3.03,9.01 0001564590-20-045822 001-34375 201223663 34 64382
2020-09-15 8-K 8-K FAST TRACK 8.01,9.01 0001564590-20-043477 001-34375 201174676 34 39613
2020-08-26 4 FORM 4 SUBMISSION 0001209191-20-048319 4696
2020-08-14 4 FORM 4 SUBMISSION 0001209191-20-046715 4669
2020-08-13 4 FORM 4 SUBMISSION 0001209191-20-046504 4669
2020-08-13 4 FORM 4 SUBMISSION 0001209191-20-046503 4758
2020-08-10 8-K 8-K 2.02,9.01 0001564590-20-038560 001-34375 201086961 34 527983
2020-08-10 10-Q 10-Q 0001564590-20-038551 001-34375 201086918 34 5914828 1
2020-08-04 8-K 8-K WARRANT AMENDMENT AUGUST 2020 3.03,9.01 0001564590-20-036123 001-34375 201073487 34 30157
2020-07-01 4 FORM 4 SUBMISSION 0001209191-20-039563 5544
2020-06-30 S-8 S-8 0001564590-20-031140 333-239548 201000322 33 490697
2020-06-29 4 FORM 4 SUBMISSION 0001209191-20-039325 5477
2020-06-29 4 FORM 4 SUBMISSION 0001209191-20-039322 5542
2020-06-29 4 FORM 4 SUBMISSION 0001209191-20-039319 9695
2020-06-29 4 FORM 4 SUBMISSION 0001209191-20-039316 5429
2020-06-23 4 FORM 4 SUBMISSION 0001209191-20-038639 8934

Latest XBRL company facts

One latest value per concept from companyfacts (481 concepts). Full history stays in the JSON.

TaxonomyTagLabelUnitValueStartEndFYFPFormFiledAccn
dei EntityCommonStockSharesOutstanding Entity Common Stock, Shares Outstanding shares 9.78M 2026-11-09 2026 Q3 10-Q 2026-11-13 0001193125-26-460950
dei EntityPublicFloat Entity Public Float USD 31.90M 2025-06-30 2025 FY 10-K 2026-03-12 0001193125-26-104258
ffd NetFeeAmt NetFeeAmt USD 0 2026-05-29 S-3 2026-06-02 0001193125-26-252119
ffd TtlFeeAmt TtlFeeAmt USD 13,810 2026-05-29 S-3 2026-06-02 0001193125-26-252119
ffd TtlOfferingAmt TtlOfferingAmt USD 100.00M 2026-05-29 S-3 2026-06-02 0001193125-26-252119
ffd TtlOffsetAmt TtlOffsetAmt USD 13,810 2026-05-29 S-3 2026-06-02 0001193125-26-252119
ffd TtlPrevslyPdAmt TtlPrevslyPdAmt USD 0 2026-05-29 S-3 2026-06-02 0001193125-26-252119
us-gaap AccountsPayableAndAccruedLiabilitiesCurrent Accounts Payable and Accrued Liabilities, Current USD 8.21M 2026-09-30 2026 Q3 10-Q 2026-11-13 0001193125-26-460950
us-gaap AccountsPayableCurrent Accounts Payable, Current USD 3.28M 2025-12-31 2025 FY 10-K 2026-03-12 0001193125-26-104258
us-gaap AccountsReceivableNetCurrent Accounts Receivable, after Allowance for Credit Loss, Current USD 722,000 2026-09-30 2026 Q3 10-Q 2026-11-13 0001193125-26-460950
us-gaap AccretionAmortizationOfDiscountsAndPremiumsInvestments Accretion (Amortization) of Discounts and Premiums, Investments USD 18,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-13 0001193125-26-460950
us-gaap AccretionExpense Accretion Expense USD 0 2017-01-01 2017-12-31 2017 FY 10-K 2018-03-09 0001564590-18-005136
us-gaap AccruedBonusesCurrent Accrued Bonuses, Current USD 993,000 2025-12-31 2025 FY 10-K 2026-03-12 0001193125-26-104258
us-gaap AccruedProfessionalFeesCurrent Accrued Professional Fees, Current USD 183,000 2025-12-31 2025 FY 10-K 2026-03-12 0001193125-26-104258
us-gaap AccruedRentCurrent Accrued Rent, Current USD 215,000 2016-12-31 2016 FY 10-K 2017-03-24 0001564590-17-005251
us-gaap AccruedSalariesCurrent Accrued Salaries, Current USD 118,000 2014-12-31 2014 FY 10-K 2015-03-16 0001140361-15-011947
us-gaap AccruedVacationCurrent Accrued Vacation, Current USD 192,000 2018-12-31 8-K 2019-09-10 0001564590-19-034402
us-gaap AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment USD 3.33M 2025-12-31 2025 FY 10-K 2026-03-12 0001193125-26-104258
us-gaap AccumulatedOtherComprehensiveIncomeLossNetOfTax Accumulated Other Comprehensive Income (Loss), Net of Tax USD 1.22M 2018-12-31 2019 FY 10-K 2020-03-30 0001564590-20-014165
us-gaap AdditionalPaidInCapital Additional Paid in Capital USD 540.04M 2026-09-30 2026 Q3 10-Q 2026-11-13 0001193125-26-460950
us-gaap AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue APIC, Share-based Payment Arrangement, Increase for Cost Recognition USD 709,000 2026-07-01 2026-09-30 2026 Q3 10-Q 2026-11-13 0001193125-26-460950
us-gaap AdjustmentsToAdditionalPaidInCapitalWarrantIssued Adjustments to Additional Paid in Capital, Warrant Issued USD 776,000 2015-01-01 2015-12-31 2016 FY 10-K 2017-03-24 0001564590-17-005251
us-gaap AllocatedShareBasedCompensationExpenseNetOfTax Share-based Payment Arrangement, Expense, after Tax USD 0 2019-01-01 2019-12-31 2019 FY 10-K 2020-03-30 0001564590-20-014165
us-gaap AllowanceForDoubtfulAccountsReceivableCurrent Accounts Receivable, Allowance for Credit Loss, Current USD 181,000 2019-06-30 2019 Q2 10-Q 2019-08-15 0001564590-19-032349
us-gaap AmortizationOfDebtDiscountPremium Amortization of Debt Discount (Premium) USD 21,000 2024-01-01 2024-03-31 2024 Q1 10-Q 2024-05-15 0000950170-24-060395
us-gaap AmortizationOfDeferredCharges Amortization of Deferred Charges USD 979.00M 2015-01-01 2015-12-31 2015 FY 10-K 2016-03-11 0001140361-16-057505
us-gaap AmortizationOfFinancingCostsAndDiscounts Amortization of Debt Issuance Costs and Discounts USD 20,000 2024-01-01 2024-09-30 2025 Q3 10-Q 2025-10-30 0001193125-25-258596
us-gaap AmortizationOfIntangibleAssets Amortization of Intangible Assets USD 100,000 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-12 0001193125-26-104258
us-gaap AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount shares 4.03M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-13 0001193125-26-460950
us-gaap AreaOfLand Area of Land sqft 11,370 2026-08-10 2026 Q3 10-Q 2026-11-13 0001193125-26-460950
us-gaap AssetImpairmentCharges Asset Impairment Charges USD 0 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-13 0001193125-26-460950
us-gaap Assets Assets USD 12.20M 2026-09-30 2026 Q3 10-Q 2026-11-13 0001193125-26-460950
us-gaap AssetsCurrent Assets, Current USD 8.07M 2026-09-30 2026 Q3 10-Q 2026-11-13 0001193125-26-460950
us-gaap AssetsOfDisposalGroupIncludingDiscontinuedOperation Disposal Group, Including Discontinued Operation, Assets USD 0 2020-12-31 2020 FY 10-K 2021-02-22 0001564590-21-007165
us-gaap AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent Disposal Group, Including Discontinued Operation, Assets, Current USD 3.28M 2018-12-31 2019 FY 10-K 2020-03-30 0001564590-20-014165
us-gaap AvailableForSaleDebtSecuritiesAmortizedCostBasis Debt Securities, Available-for-sale, Amortized Cost USD 3.99M 2026-09-30 2026 Q3 10-Q 2026-11-13 0001193125-26-460950
us-gaap AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsAmortizedCost Debt Securities, Available-for-Sale, Amortized Cost, Maturity, Allocated and Single Maturity Date, after Year 5 Through 10 USD 2.30M 2026-09-30 2026 Q3 10-Q 2026-11-13 0001193125-26-460950
us-gaap AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsFairValue Debt Securities, Available-for-Sale, Fair Value, Maturity, Allocated and Single Maturity Date, after Year 5 Through 10 USD 2.30M 2026-09-30 2026 Q3 10-Q 2026-11-13 0001193125-26-460950
us-gaap AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsAmortizedCost Debt Securities, Available-for-Sale, Amortized Cost, Maturity, Allocated and Single Maturity Date, after Year One Through Five USD 0 2026-09-30 2026 Q3 10-Q 2026-11-13 0001193125-26-460950
us-gaap AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue Debt Securities, Available-for-Sale, Fair Value, Maturity, Allocated and Single Maturity Date, after Year One Through Five USD 0 2026-09-30 2026 Q3 10-Q 2026-11-13 0001193125-26-460950
us-gaap AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost Debt Securities, Available-for-Sale, Amortized Cost, Maturity, Allocated and Single Maturity Date, Year One USD 1.69M 2026-09-30 2026 Q3 10-Q 2026-11-13 0001193125-26-460950
us-gaap AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue Debt Securities, Available-for-Sale, Fair Value, Maturity, Allocated and Single Maturity Date, Year One USD 1.69M 2026-09-30 2026 Q3 10-Q 2026-11-13 0001193125-26-460950
us-gaap AvailableForSaleSecuritiesDebtSecurities Debt Securities, Available-for-sale USD 3.99M 2026-09-30 2026 Q3 10-Q 2026-11-13 0001193125-26-460950
us-gaap BeneficialInterest Beneficial Interest Liability USD 0 2013-12-31 2014 FY 10-K 2015-03-16 0001140361-15-011947
us-gaap BusinessAcquisitionContingentConsiderationAtFairValue Business Acquisition, Contingent Consideration, at Fair Value (Deprecated 2013-01-31) USD 10.00M 2014-03-31 2014 Q1 10-Q 2014-05-12 0001140361-14-020172
us-gaap BusinessCombinationConsiderationTransferred Business Combination, Consideration Transferred (Deprecated 2013-01-31) USD 5.00M 2014-03-31 2014 Q1 10-Q 2014-05-12 0001140361-14-020172
us-gaap BusinessCombinationConsiderationTransferred1 Business Combination, Consideration Transferred USD 5.00M 2013-01-01 2013-12-31 2015 FY 10-K 2016-03-11 0001140361-16-057505
us-gaap BusinessCombinationLiabilitiesArisingFromContingenciesAmountRecognized Business Combination, Liabilities Arising from Contingencies, Amount Recognized USD 10.00M 2013-12-31 2015 FY 10-K 2016-03-11 0001140361-16-057505
us-gaap BusinessCombinationStepAcquisitionEquityInterestInAcquireeRemeasurementGain Business Combination, Step Acquisition, Equity Interest in Acquiree, Remeasurement Gain USD 0 2015-01-01 2015-12-31 2015 FY 10-K 2016-03-11 0001140361-16-057505
us-gaap CapitalExpendituresIncurredButNotYetPaid Capital Expenditures Incurred but Not yet Paid USD 0 2013-01-01 2013-03-31 2013 Q1 10-Q 2013-05-10 0001140361-13-020095
us-gaap CapitalLeaseObligationsIncurred Lease Obligation Incurred USD 0 2013-01-01 2013-12-31 2013 FY 10-K 2014-03-14 0001140361-14-012811
us-gaap CashAndCashEquivalentsAtCarryingValue Cash and Cash Equivalents, at Carrying Value USD 879,000 2026-09-30 2026 Q3 10-Q 2026-11-13 0001193125-26-460950
us-gaap CashAndCashEquivalentsPeriodIncreaseDecrease Cash and Cash Equivalents, Period Increase (Decrease) USD -4.28M 2018-01-01 2018-03-31 2018 Q1 10-Q 2018-05-11 0001564590-18-013252
us-gaap CashCashEquivalentsAndShortTermInvestments Cash, Cash Equivalents, and Short-term Investments USD 13.10M 2025-12-31 2025 FY 10-K 2026-03-12 0001193125-26-104258
us-gaap CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents USD 5.94M 2018-03-31 2018 Q1 10-Q 2018-05-11 0001564590-18-013252
us-gaap CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Including Disposal Group and Discontinued Operations USD 879,000 2026-09-30 2026 Q3 10-Q 2026-11-13 0001193125-26-460950
us-gaap CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect USD -7.88M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-13 0001193125-26-460950
us-gaap CashEquivalentsAtCarryingValue Cash Equivalents, at Carrying Value USD 0 2022-12-31 2022 FY 10-K 2023-02-23 0000950170-23-004099
us-gaap ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights Class of Warrant or Right, Exercise Price of Warrants or Rights (Deprecated 2014-01-31) USD/shares_unit 25 2013-12-31 2013 FY 10-K 2014-03-14 0001140361-14-012811
us-gaap ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1 Class of Warrant or Right, Exercise Price of Warrants or Rights USD/shares 2.25 2020-12-31 2021 FY 10-K 2022-02-24 0001564590-22-006708
us-gaap ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights Class of Warrant or Right, Number of Securities Called by Warrants or Rights shares 2.30M 2018-05-24 2019 FY 10-K 2020-03-30 0001564590-20-014165
us-gaap ClassOfWarrantOrRightOutstanding Class of Warrant or Right, Outstanding shares 1.82M 2026-09-30 2026 Q3 10-Q 2026-11-13 0001193125-26-460950
us-gaap CommitmentsAndContingencies Commitments and Contingencies USD 0 2013-06-30 2013 Q2 10-Q 2013-08-09 0001140361-13-031507
us-gaap CommonStockCapitalSharesReservedForFutureIssuance Common Stock, Capital Shares Reserved for Future Issuance shares 3.72M 2014-09-30 2014 Q3 10-Q 2014-11-07 0001140361-14-040582
us-gaap CommonStockParOrStatedValuePerShare Common Stock, Par or Stated Value Per Share USD/shares 0.001 2026-09-30 2026 Q3 10-Q 2026-11-13 0001193125-26-460950
us-gaap CommonStockSharesAuthorized Common Stock, Shares Authorized shares 2.00B 2026-09-30 2026 Q3 10-Q 2026-11-13 0001193125-26-460950
us-gaap CommonStockSharesIssued Common Stock, Shares, Issued shares 7.89M 2026-09-30 2026 Q3 10-Q 2026-11-13 0001193125-26-460950
us-gaap CommonStockSharesOutstanding Common Stock, Shares, Outstanding shares 7.88M 2026-09-30 2026 Q3 10-Q 2026-11-13 0001193125-26-460950
us-gaap CommonStockValue Common Stock, Value, Issued USD 8,000 2026-09-30 2026 Q3 10-Q 2026-11-13 0001193125-26-460950
us-gaap ComprehensiveIncomeNetOfTax Comprehensive Income (Loss), Net of Tax, Attributable to Parent USD -1.09M 2020-01-01 2020-03-31 2020 Q1 10-Q 2020-05-14 0001564590-20-025453
us-gaap ConcentrationRiskPercentage1 Concentration Risk, Percentage pure 1 2018-01-01 2018-09-30 2018 Q3 10-Q 2018-11-14 0001564590-18-029586
us-gaap ContractualObligation Contractual Obligation USD 5.60M 2022-12-31 2022 FY 10-K 2023-02-23 0000950170-23-004099
us-gaap ContractualObligationDueInFourthYear Contractual Obligation, to be Paid, Year Four USD 3.76M 2020-12-31 2020 FY 10-K 2021-02-22 0001564590-21-007165
us-gaap ContractualObligationDueInNextTwelveMonths Contractual Obligation, to be Paid, Year One USD 1.61M 2022-12-31 2022 FY 10-K 2023-02-23 0000950170-23-004099
us-gaap ContractualObligationDueInSecondYear Contractual Obligation, to be Paid, Year Two USD 4.00M 2022-12-31 2022 FY 10-K 2023-02-23 0000950170-23-004099
us-gaap ContractualObligationDueInThirdYear Contractual Obligation, to be Paid, Year Three USD 4.00M 2021-12-31 2021 FY 10-K 2022-02-24 0001564590-22-006708
us-gaap ContractWithCustomerLiabilityNoncurrent Contract with Customer, Liability, Noncurrent USD 142,000 2019-03-31 2019 Q1 10-Q 2019-05-14 0001564590-19-019181
us-gaap ConversionOfStockAmountConverted1 Conversion of Stock, Amount Converted USD 0 2019-01-01 2019-12-31 2019 FY 10-K 2020-03-30 0001564590-20-014165
us-gaap ConvertibleDebtCurrent Convertible Debt, Current USD 3.85M 2026-09-30 2026 Q3 10-Q 2026-11-13 0001193125-26-460950
us-gaap CostOfGoodsAndServicesSold Cost of Goods and Services Sold USD 1.15M 2018-01-01 2018-12-31 2018 FY 10-K 2019-03-29 0001564590-19-010018
us-gaap CostOfGoodsAndServicesSoldAmortization Cost, Amortization USD 306,000 2019-01-01 2019-03-31 2019 Q1 10-Q 2019-05-14 0001564590-19-019181
us-gaap CostOfGoodsSold Cost of Goods Sold (Deprecated 2018-01-31) USD 2.71M 2016-01-01 2016-12-31 2016 FY 10-K 2017-03-24 0001564590-17-005251
us-gaap CostOfGoodsSoldAmortization Cost of Goods Sold, Amortization (Deprecated 2018-01-31) USD 306,000 2018-01-01 2018-03-31 2018 Q1 10-Q 2018-05-11 0001564590-18-013252
us-gaap CurrentFederalStateAndLocalTaxExpenseBenefit Current Federal, State and Local, Tax Expense (Benefit) USD 0 2015-01-01 2015-12-31 2016 FY 10-K 2017-03-24 0001564590-17-005251
us-gaap DebtInstrumentCarryingAmount Long-term Debt, Gross USD 22.27M 2012-12-31 2012 FY 10-K 2013-03-15 0001140361-13-012755
us-gaap DebtInstrumentFaceAmount Debt Instrument, Face Amount USD 25.00M 2012-12-31 2012 FY 10-K 2013-03-15 0001140361-13-012755
us-gaap DebtInstrumentInterestRateEffectivePercentage Debt Instrument, Interest Rate, Effective Percentage pure 0.139 2013-06-28 2014 Q1 10-Q 2014-05-12 0001140361-14-020172
us-gaap DebtInstrumentInterestRateStatedPercentage Debt Instrument, Interest Rate, Stated Percentage pure 0.099 2012-12-31 2012 FY 10-K 2013-03-15 0001140361-13-012755
us-gaap DebtInstrumentPeriodicPayment Debt Instrument, Periodic Payment USD 1.00M 2014-01-01 2014-12-31 2014 FY 10-K 2015-03-16 0001140361-15-011947
us-gaap DebtInstrumentPeriodicPaymentPrincipal Debt Instrument, Periodic Payment, Principal USD 600,000 2017-01-01 2017-06-30 2017 Q2 10-Q 2017-08-11 0001564590-17-017438
us-gaap DebtInstrumentUnamortizedDiscount Debt Instrument, Unamortized Discount USD 210,000 2022-12-31 2022 FY 10-K 2023-02-23 0000950170-23-004099
us-gaap DebtLongtermAndShorttermCombinedAmount Debt, Long-term and Short-term, Combined Amount USD 25.40M 2014-12-31 2014 FY 10-K 2015-03-16 0001140361-15-011947
us-gaap DebtSecuritiesAvailableForSaleRealizedGainLoss Debt Securities, Available-for-sale, Realized Gain (Loss) USD -200,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-13 0001193125-26-460950
us-gaap DeferredFederalStateAndLocalTaxExpenseBenefit Deferred Federal, State and Local, Tax Expense (Benefit) USD 0 2015-01-01 2015-12-31 2016 FY 10-K 2017-03-24 0001564590-17-005251
us-gaap DeferredIncomeCurrent Deferred Income, Current USD 927,000 2026-09-30 2026 Q3 10-Q 2026-11-13 0001193125-26-460950
us-gaap DeferredIncomeNoncurrent Deferred Income, Noncurrent USD 1.92M 2023-12-31 2024 FY 10-K 2025-03-31 0000950170-25-047698
us-gaap DeferredIncomeTaxLiabilities Deferred Tax Liabilities, Gross USD 15,000 2025-12-31 2025 FY 10-K 2026-03-12 0001193125-26-104258
us-gaap DeferredRentCreditNoncurrent Deferred Rent Credit, Noncurrent USD 8,000 2026-09-30 2026 Q3 10-Q 2026-11-13 0001193125-26-460950
us-gaap DeferredRevenue Deferred Revenue USD 217,000 2018-06-30 2018 Q2 10-Q 2018-08-14 0001564590-18-021735
us-gaap DeferredRevenueRevenueRecognized Deferred Revenue, Revenue Recognized (Deprecated 2016-01-31) USD 0 2013-01-01 2013-12-31 2014 FY 10-K 2015-03-16 0001140361-15-011947
us-gaap DeferredTaxAssetsDeferredIncome Deferred Tax Assets, Deferred Income USD 33,000 2016-12-31 2016 FY 10-K 2017-03-24 0001564590-17-005251
us-gaap DeferredTaxAssetsGoodwillAndIntangibleAssets Deferred Tax Assets, Goodwill and Intangible Assets USD 853,000 2025-12-31 2025 FY 10-K 2026-03-12 0001193125-26-104258
us-gaap DeferredTaxAssetsGross Deferred Tax Assets, Gross USD 25.93M 2025-12-31 2025 FY 10-K 2026-03-12 0001193125-26-104258
us-gaap DeferredTaxAssetsInProcessResearchAndDevelopment Deferred Tax Assets, in Process Research and Development USD 2.86M 2025-12-31 2025 FY 10-K 2026-03-12 0001193125-26-104258
us-gaap DeferredTaxAssetsNet Deferred Tax Assets, Net of Valuation Allowance USD 15,000 2025-12-31 2025 FY 10-K 2026-03-12 0001193125-26-104258
us-gaap DeferredTaxAssetsOperatingLossCarryforwards Deferred Tax Assets, Operating Loss Carryforwards USD 19.27M 2025-12-31 2025 FY 10-K 2026-03-12 0001193125-26-104258
us-gaap DeferredTaxAssetsOperatingLossCarryforwardsDomestic Deferred Tax Assets, Operating Loss Carryforwards, Domestic USD 4.10M 2012-12-31 2012 FY 10-K 2013-03-15 0001140361-13-012755
us-gaap DeferredTaxAssetsOperatingLossCarryforwardsStateAndLocal Deferred Tax Assets, Operating Loss Carryforwards, State and Local USD 5.50M 2020-12-31 2021 FY 10-K 2022-02-24 0001564590-22-006708
us-gaap DeferredTaxAssetsOther Deferred Tax Assets, Other USD 213,000 2025-12-31 2025 FY 10-K 2026-03-12 0001193125-26-104258
us-gaap DeferredTaxAssetsPropertyPlantAndEquipment Deferred Tax Assets, Property, Plant and Equipment USD 206,000 2025-12-31 2025 FY 10-K 2026-03-12 0001193125-26-104258
us-gaap DeferredTaxAssetsTaxCreditCarryforwards Deferred Tax Assets, Tax Credit Carryforwards USD 2.11M 2025-12-31 2025 FY 10-K 2026-03-12 0001193125-26-104258
us-gaap DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefits Deferred Tax Assets, Tax Deferred Expense, Compensation and Benefits USD 1.30M 2016-12-31 2016 FY 10-K 2017-03-24 0001564590-17-005251
us-gaap DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost Deferred Tax Assets, Tax Deferred Expense, Compensation and Benefits, Share-based Compensation Cost USD 106,000 2025-12-31 2025 FY 10-K 2026-03-12 0001193125-26-104258
us-gaap DeferredTaxAssetsTaxDeferredExpenseReservesAndAccruals Deferred Tax Assets, Tax Deferred Expense, Reserves and Accruals USD 6,000 2019-12-31 2020 FY 10-K 2021-02-22 0001564590-21-007165
us-gaap DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities Deferred Tax Assets, Tax Deferred Expense, Reserves and Accruals, Accrued Liabilities USD 302,000 2025-12-31 2025 FY 10-K 2026-03-12 0001193125-26-104258
us-gaap DeferredTaxAssetsValuationAllowance Deferred Tax Assets, Valuation Allowance USD 25.91M 2025-12-31 2025 FY 10-K 2026-03-12 0001193125-26-104258
us-gaap DeferredTaxLiabilities Deferred Tax Liabilities, Net USD 0 2025-12-31 2025 FY 10-K 2026-03-12 0001193125-26-104258
us-gaap DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsIntangibleAssets Deferred Tax Liabilities, Intangible Assets USD 751,000 2018-12-31 8-K 2019-09-10 0001564590-19-034402
us-gaap DeferredTaxLiabilitiesOther Deferred Tax Liabilities, Other USD 15,000 2025-12-31 2025 FY 10-K 2026-03-12 0001193125-26-104258
us-gaap DefinedContributionPlanEmployerDiscretionaryContributionAmount Defined Contribution Plan, Employer Discretionary Contribution Amount USD 100,000 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-12 0001193125-26-104258
us-gaap Deposits Deposits USD -525,000 2015-12-31 2015 FY 10-K 2016-03-11 0001140361-16-057505
us-gaap DepositsAssets Deposits Assets USD 39,000 2018-12-31 8-K 2019-09-10 0001564590-19-034402
us-gaap Depreciation Depreciation USD 200,000 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-12 0001193125-26-104258
us-gaap DepreciationAndAmortizationDiscontinuedOperations Depreciation and Amortization, Discontinued Operations USD 467,000 2019-01-01 2019-12-31 2020 FY 10-K 2021-02-22 0001564590-21-007165
us-gaap DepreciationDepletionAndAmortization Depreciation, Depletion and Amortization USD 378,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-13 0001193125-26-460950
us-gaap DerivativeFinancialInstrumentsLiabilitiesFairValueDisclosure Derivative Financial Instruments, Liabilities, Fair Value Disclosure (Deprecated 2013-01-31) USD 1.87M 2012-09-30 2012 Q3 10-Q 2012-11-09 0001140361-12-046470
us-gaap DiscontinuedOperationGainLossOnDisposalOfDiscontinuedOperationNetOfTax Discontinued Operation, Gain (Loss) on Disposal of Discontinued Operation, Net of Tax USD -6.51M 2019-01-01 2019-12-31 2020 FY 10-K 2021-02-22 0001564590-21-007165
us-gaap DiscontinuedOperationIncomeLossFromDiscontinuedOperationNetOfTaxPerBasicAndDilutedShare Discontinued Operation, Income (Loss) from Discontinued Operation, Net of Tax, Per Basic and Diluted Share USD/shares 0 2020-01-01 2020-12-31 2020 FY 10-K 2021-02-22 0001564590-21-007165
us-gaap DisposalGroupIncludingDiscontinuedOperationAssetsNoncurrent Disposal Group, Including Discontinued Operation, Assets, Noncurrent USD 11.63M 2018-12-31 2019 FY 10-K 2020-03-30 0001564590-20-014165
us-gaap DisposalGroupIncludingDiscontinuedOperationCostsOfGoodsSold Disposal Group, Including Discontinued Operation, Costs of Goods Sold USD 857,000 2019-01-01 2019-12-31 2020 FY 10-K 2021-02-22 0001564590-21-007165
us-gaap DisposalGroupIncludingDiscontinuedOperationGeneralAndAdministrativeExpense Disposal Group, Including Discontinued Operation, General and Administrative Expense USD 185,000 2019-01-01 2019-12-31 2020 FY 10-K 2021-02-22 0001564590-21-007165
us-gaap DisposalGroupIncludingDiscontinuedOperationGrossProfitLoss Disposal Group, Including Discontinued Operation, Gross Profit (Loss) USD 44,000 2019-01-01 2019-12-31 2020 FY 10-K 2021-02-22 0001564590-21-007165
us-gaap DisposalGroupIncludingDiscontinuedOperationOperatingExpense Disposal Group, Including Discontinued Operation, Operating Expense USD 1.25M 2019-01-01 2019-12-31 2020 FY 10-K 2021-02-22 0001564590-21-007165
us-gaap DisposalGroupIncludingDiscontinuedOperationOperatingIncomeLoss Disposal Group, Including Discontinued Operation, Operating Income (Loss) USD -1.21M 2019-01-01 2019-12-31 2020 FY 10-K 2021-02-22 0001564590-21-007165
us-gaap DisposalGroupIncludingDiscontinuedOperationRevenue Disposal Group, Including Discontinued Operation, Revenue USD 901,000 2019-01-01 2019-12-31 2020 FY 10-K 2021-02-22 0001564590-21-007165
us-gaap DividendsPayableCurrentAndNoncurrent Dividends Payable USD 1.20M 2014-12-31 2014 FY 10-K 2015-03-16 0001140361-15-011947
us-gaap EarningsPerShareBasic Earnings Per Share, Basic USD/shares -3.5 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-13 0001193125-26-460950
us-gaap EarningsPerShareBasicAndDiluted Earnings Per Share, Basic and Diluted USD/shares -0.19 2022-01-01 2022-03-31 2022 Q1 10-Q 2022-04-21 0001564590-22-015075
us-gaap EarningsPerShareDiluted Earnings Per Share, Diluted USD/shares -3.5 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-13 0001193125-26-460950
us-gaap EffectiveIncomeTaxRateContinuingOperations Effective Income Tax Rate Reconciliation, Percent pure 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-12 0001193125-26-104258
us-gaap EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent pure -0.21 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-12 0001193125-26-104258
us-gaap EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance Effective Income Tax Rate Reconciliation, Change in Deferred Tax Assets Valuation Allowance, Percent pure 0.139 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-12 0001193125-26-104258
us-gaap EffectiveIncomeTaxRateReconciliationCrossBorderTaxEffectAmount EffectiveIncomeTaxRateReconciliationCrossBorderTaxEffectAmount USD 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-12 0001193125-26-104258
us-gaap EffectiveIncomeTaxRateReconciliationCrossBorderTaxEffectPercent EffectiveIncomeTaxRateReconciliationCrossBorderTaxEffectPercent pure 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-12 0001193125-26-104258
us-gaap EffectiveIncomeTaxRateReconciliationDispositionOfAssets Effective Income Tax Rate Reconciliation, Disposition of Asset, Percent pure 0 2015-01-01 2015-12-31 2015 FY 10-K 2016-03-11 0001140361-16-057505
us-gaap EffectiveIncomeTaxRateReconciliationDispositionOfBusiness Effective Income Tax Rate Reconciliation, Disposition of Business, Percent pure 0 2015-01-01 2015-12-31 2015 FY 10-K 2016-03-11 0001140361-16-057505
us-gaap EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential Effective Income Tax Rate Reconciliation, Foreign Income Tax Rate Differential, Percent pure 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-12 0001193125-26-104258
us-gaap EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost Effective Income Tax Rate Reconciliation, Nondeductible Expense, Share-based Payment Arrangement, Percent pure 0.013 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-12 0001193125-26-104258
us-gaap EffectiveIncomeTaxRateReconciliationOtherAdjustments Effective Income Tax Rate Reconciliation, Other Adjustments, Percent pure 0.003 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-12 0001193125-26-104258
us-gaap EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes Effective Income Tax Rate Reconciliation, State and Local Income Taxes, Percent pure -0.002 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-12 0001193125-26-104258
us-gaap EffectiveIncomeTaxRateReconciliationTaxContingencies Effective Income Tax Rate Reconciliation, Tax Contingency, Percent pure 0.006 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-12 0001193125-26-104258
us-gaap EffectiveIncomeTaxRateReconciliationTaxCreditsResearch Effective Income Tax Rate Reconciliation, Tax Credit, Research, Percent pure 0.016 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-12 0001193125-26-104258
us-gaap EffectiveIncomeTaxRateReconciliationTaxSettlementsStateAndLocal Effective Income Tax Rate Reconciliation, Tax Settlement, State and Local, Percent pure 0 2023-01-01 2023-12-31 2023 FY 10-K 2024-03-05 0000950170-24-025851
us-gaap EffectOfExchangeRateOnCashAndCashEquivalents Effect of Exchange Rate on Cash and Cash Equivalents USD 39,000 2018-01-01 2018-03-31 2018 Q1 10-Q 2018-05-11 0001564590-18-013252
us-gaap EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations Effect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Including Disposal Group and Discontinued Operations USD 0 2020-01-01 2020-12-31 2020 FY 10-K 2021-02-22 0001564590-21-007165
us-gaap EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized Share-based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Amount USD 5.00M 2026-09-30 2026 Q3 10-Q 2026-11-13 0001193125-26-460950
us-gaap EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense Share-based Payment Arrangement, Expense, Tax Benefit USD 0 2016-01-01 2016-12-31 2016 FY 10-K 2017-03-24 0001564590-17-005251
us-gaap EquityMethodInvestmentAggregateCost Equity Method Investment, Aggregate Cost USD 6.00M 2015-04-30 2017 FY 10-K 2018-03-09 0001564590-18-005136
us-gaap EquityMethodInvestmentOwnershipPercentage Equity Method Investment, Ownership Percentage pure 0.5 2014-12-31 2014 FY 10-K 2015-03-16 0001140361-15-011947
us-gaap EquityMethodInvestments Equity Method Investments USD 0 2013-12-31 2013 FY 10-K 2014-03-14 0001140361-14-012811
us-gaap ExtinguishmentOfDebtAmount Extinguishment of Debt, Amount USD 18.87M 2013-01-01 2013-12-31 2013 FY 10-K 2014-03-14 0001140361-14-012811
us-gaap ExtinguishmentOfDebtGainLossNetOfTax Extinguishment of Debt, Gain (Loss), Net of Tax USD 0 2016-01-01 2016-12-31 2016 FY 10-K 2017-03-24 0001564590-17-005251
us-gaap FairValueAdjustmentOfWarrants Fair Value Adjustment of Warrants USD 800,000 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-12 0001193125-26-104258
us-gaap FairValueAssumptionsExpectedVolatilityRate Fair Value Assumptions, Expected Volatility Rate (Deprecated 2018-01-31) pure 0.9 2014-01-01 2014-12-31 2014 FY 10-K 2015-03-16 0001140361-15-011947
us-gaap FairValueAssumptionsRiskFreeInterestRate Fair Value Assumptions, Risk Free Interest Rate (Deprecated 2018-01-31) pure 0.017 2014-01-01 2014-12-31 2014 FY 10-K 2015-03-16 0001140361-15-011947
us-gaap FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityIssues Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Issuances USD 16.01M 2025-01-01 2025-09-30 2026 Q3 10-Q 2026-11-13 0001193125-26-460950
us-gaap FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPeriodIncreaseDecrease Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Period Increase (Decrease) USD 3.15M 2025-01-01 2025-09-30 2026 Q3 10-Q 2026-11-13 0001193125-26-460950
us-gaap FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Settlements USD 1.39M 2025-01-01 2025-09-30 2026 Q3 10-Q 2026-11-13 0001193125-26-460950
us-gaap FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability Value USD 0 2025-09-30 2026 Q3 10-Q 2026-11-13 0001193125-26-460950
us-gaap FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputsReconciliationIssues Fair Value, Net Derivative Asset (Liability) Measured on Recurring Basis, Unobservable Inputs Reconciliation, Issues USD 4.44M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-13 0001193125-26-460950
us-gaap FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputsReconciliationPeriodIncreaseDecrease Fair Value, Net Derivative Asset (Liability) Measured on Recurring Basis, Unobservable Inputs Reconciliation, Period Increase (Decrease) USD -490,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-13 0001193125-26-460950
us-gaap FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisWithUnobservableInputs Fair Value, Net Derivative Asset (Liability) Measured on Recurring Basis with Unobservable Inputs USD 3.95M 2026-09-30 2026 Q3 10-Q 2026-11-13 0001193125-26-460950
us-gaap FinanceLeaseInterestExpense Finance Lease, Interest Expense USD 4,000 2020-01-01 2020-12-31 2021 FY 10-K 2022-02-24 0001564590-22-006708
us-gaap FinanceLeaseLiability Finance Lease, Liability USD 10,000 2020-12-31 2021 FY 10-K 2022-02-24 0001564590-22-006708
us-gaap FinanceLeaseLiabilityCurrent Finance Lease, Liability, Current USD 10,000 2020-12-31 2021 FY 10-K 2022-02-24 0001564590-22-006708
us-gaap FinanceLeaseLiabilityNoncurrent Finance Lease, Liability, Noncurrent USD 3,000 2021-03-31 2021 Q1 10-Q 2021-04-22 0001564590-21-020103
us-gaap FinanceLeaseLiabilityPaymentsDue Finance Lease, Liability, Payment, Due USD 3,000 2021-03-31 2021 Q1 10-Q 2021-04-22 0001564590-21-020103
us-gaap FinanceLeaseLiabilityPaymentsDueNextTwelveMonths Finance Lease, Liability, to be Paid, Year One USD 3,000 2021-03-31 2021 Q1 10-Q 2021-04-22 0001564590-21-020103
us-gaap FinanceLeaseLiabilityPaymentsDueYearThree Finance Lease, Liability, to be Paid, Year Three USD 7,000 2019-09-30 2019 Q3 10-Q 2019-11-14 0001564590-19-043516
us-gaap FinanceLeaseLiabilityPaymentsDueYearTwo Finance Lease, Liability, to be Paid, Year Two USD 7,000 2020-09-30 2020 Q3 10-Q 2020-10-22 0001564590-20-047266
us-gaap FinanceLeaseLiabilityPaymentsRemainderOfFiscalYear Finance Lease, Liability, to be Paid, Remainder of Fiscal Year USD 72,000 2020-06-30 2020 Q2 10-Q 2020-08-10 0001564590-20-038551
us-gaap FinanceLeaseLiabilityUndiscountedExcessAmount Finance Lease, Liability, Undiscounted Excess Amount USD 0 2020-03-31 2020 Q1 10-Q 2020-05-14 0001564590-20-025453
us-gaap FinanceLeasePrincipalPayments Finance Lease, Principal Payments USD 0 2022-01-01 2022-12-31 2022 FY 10-K 2023-02-23 0000950170-23-004099
us-gaap FinanceLeaseRightOfUseAsset Finance Lease, Right-of-Use Asset, after Accumulated Amortization USD 7,000 2020-12-31 2021 FY 10-K 2022-02-24 0001564590-22-006708
us-gaap FinanceLeaseRightOfUseAssetAmortization Finance Lease, Right-of-Use Asset, Amortization USD 7,000 2021-01-01 2021-12-31 2022 FY 10-K 2023-02-23 0000950170-23-004099
us-gaap FinanceLeaseWeightedAverageDiscountRatePercent Finance Lease, Weighted Average Discount Rate, Percent pure 0.05 2020-12-31 2021 FY 10-K 2022-02-24 0001564590-22-006708
us-gaap FiniteLivedIntangibleAssetsAccumulatedAmortization Finite-Lived Intangible Assets, Accumulated Amortization USD 298,000 2024-12-31 2024 FY 10-K 2025-03-31 0000950170-25-047698
us-gaap FinitelivedIntangibleAssetsAcquired1 Finite-lived Intangible Assets Acquired USD 9.40M 2018-01-01 2018-12-31 2018 FY 10-K 2019-03-29 0001564590-19-010018
us-gaap FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive Finite-Lived Intangible Asset, Expected Amortization, after Year Five USD 900,000 2017-12-31 2017 FY 10-K 2018-03-09 0001564590-18-005136
us-gaap FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths Finite-Lived Intangible Asset, Expected Amortization, Year One USD 136,000 2025-12-31 2025 FY 10-K 2026-03-12 0001193125-26-104258
us-gaap FiniteLivedIntangibleAssetsAmortizationExpenseYearFive Finite-Lived Intangible Asset, Expected Amortization, Year Five USD 1.20M 2017-12-31 2017 FY 10-K 2018-03-09 0001564590-18-005136
us-gaap FiniteLivedIntangibleAssetsAmortizationExpenseYearFour Finite-Lived Intangible Asset, Expected Amortization, Year Four USD 57,000 2024-12-31 2024 FY 10-K 2025-03-31 0000950170-25-047698
us-gaap FiniteLivedIntangibleAssetsAmortizationExpenseYearThree Finite-Lived Intangible Asset, Expected Amortization, Year Three USD 61,000 2025-12-31 2025 FY 10-K 2026-03-12 0001193125-26-104258
us-gaap FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo Finite-Lived Intangible Asset, Expected Amortization, Year Two USD 136,000 2025-12-31 2025 FY 10-K 2026-03-12 0001193125-26-104258
us-gaap FiniteLivedIntangibleAssetsGross Finite-Lived Intangible Assets, Gross USD 767,000 2024-12-31 2024 FY 10-K 2025-03-31 0000950170-25-047698
us-gaap FiniteLivedIntangibleAssetsNet Finite-Lived Intangible Assets, Net USD 333,000 2025-12-31 2025 FY 10-K 2026-03-12 0001193125-26-104258
us-gaap FiniteLivedIntangibleAssetsPeriodIncreaseDecrease Finite-Lived Intangible Assets, Period Increase (Decrease) USD 13,000 2015-01-01 2015-12-31 2016 FY 10-K 2017-03-24 0001564590-17-005251
us-gaap GainLossOnDispositionOfAssets Gain (Loss) on Disposition of Property Plant Equipment, Excluding Oil and Gas Property and Timber Property USD 16,000 2025-01-01 2025-09-30 2026 Q3 10-Q 2026-11-13 0001193125-26-460950
us-gaap GainLossOnInvestments Gain (Loss) on Investments USD -179,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-13 0001193125-26-460950
us-gaap GainLossOnSaleOfBusiness Gain (Loss) on Disposition of Business USD 0 2020-01-01 2020-12-31 2020 FY 10-K 2021-02-22 0001564590-21-007165
us-gaap GainLossOnSaleOfOtherAssets Gain (Loss) on Disposition of Other Assets USD -6.51M 2019-01-01 2019-09-30 2020 Q3 10-Q 2020-10-22 0001564590-20-047266
us-gaap GeneralAndAdministrativeExpense General and Administrative Expense USD 10.48M 2026-01-01 2026-06-30 2026 Q2 10-Q 2026-08-14 0001193125-26-352444
us-gaap Goodwill Goodwill USD 372,000 2026-09-30 2026 Q3 10-Q 2026-11-13 0001193125-26-460950
us-gaap GoodwillAndIntangibleAssetImpairment Goodwill and Intangible Asset Impairment USD 0 2017-01-01 2017-12-31 2017 FY 10-K 2018-03-09 0001564590-18-005136
us-gaap GoodwillPeriodIncreaseDecrease Goodwill, Period Increase (Decrease) USD 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-12 0001193125-26-104258
us-gaap GrantsReceivableCurrent Grants Receivable, Current USD 1.76M 2026-06-30 2026 Q2 10-Q 2026-08-14 0001193125-26-352444
us-gaap GrantsReceivableNoncurrent Grants Receivable, Noncurrent USD 1.76M 2026-09-30 2026 Q3 10-Q 2026-11-13 0001193125-26-460950
us-gaap GrossProfit Gross Profit USD 412,000 2018-01-01 2018-09-30 2018 Q3 10-Q 2018-11-14 0001564590-18-029586
us-gaap ImpairmentOfIntangibleAssetsFinitelived Impairment of Intangible Assets, Finite-lived USD 0 2019-01-01 2019-03-31 8-K 2019-09-10 0001564590-19-034402
us-gaap ImpairmentOfLongLivedAssetsHeldForUse Impairment of Long-Lived Assets Held-for-use USD 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-12 0001193125-26-104258
us-gaap IncomeLossFromContinuingOperations Income (Loss) from Continuing Operations, Net of Tax, Attributable to Parent USD 500,000 2024-03-08 2025 Q3 10-Q 2025-10-30 0001193125-25-258596
us-gaap IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic Income (Loss) from Continuing Operations before Income Taxes, Domestic USD -22.39M 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-12 0001193125-26-104258
us-gaap IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest USD -22.39M 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-12 0001193125-26-104258
us-gaap IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign Income (Loss) from Continuing Operations before Income Taxes, Foreign USD 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-12 0001193125-26-104258
us-gaap IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest Income (Loss) from Continuing Operations, Net of Tax, Including Portion Attributable to Noncontrolling Interest USD -8.24M 2020-01-01 2020-12-31 2020 FY 10-K 2021-02-22 0001564590-21-007165
us-gaap IncomeLossFromContinuingOperationsPerBasicAndDilutedShare Income (Loss) from Continuing Operations, Per Basic and Diluted Share USD/shares -1.86 2020-01-01 2020-12-31 2020 FY 10-K 2021-02-22 0001564590-21-007165
us-gaap IncomeLossFromDiscontinuedOperationsNetOfTax Income (Loss) from Discontinued Operations, Net of Tax, Including Portion Attributable to Noncontrolling Interest USD 0 2020-01-01 2020-12-31 2020 FY 10-K 2021-02-22 0001564590-21-007165
us-gaap IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity Income (Loss) from Discontinued Operations, Net of Tax, Attributable to Parent USD -1.07M 2019-01-01 2019-09-30 2019 Q3 10-Q 2019-11-14 0001564590-19-043516
us-gaap IncomeLossFromEquityMethodInvestments Income (Loss) from Equity Method Investments USD 0 2015-01-01 2015-12-31 2015 FY 10-K 2016-03-11 0001140361-16-057505
us-gaap IncomeTaxExaminationPenaltiesAndInterestExpense Income Tax Examination, Penalties and Interest Expense USD 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-12 0001193125-26-104258
us-gaap IncomeTaxExpenseBenefit Income Tax Expense (Benefit) USD 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-12 0001193125-26-104258
us-gaap IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance Effective Income Tax Rate Reconciliation, Change in Deferred Tax Assets Valuation Allowance, Amount USD -3.13M 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-12 0001193125-26-104258
us-gaap IncomeTaxReconciliationChangeInEnactedTaxRate Effective Income Tax Rate Reconciliation, Change in Enacted Tax Rate, Amount USD 0 2018-01-01 2018-12-31 8-K 2019-09-10 0001564590-19-034402
us-gaap IncomeTaxReconciliationForeignIncomeTaxRateDifferential Effective Income Tax Rate Reconciliation, Foreign Income Tax Rate Differential, Amount USD 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-12 0001193125-26-104258
us-gaap IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate Effective Income Tax Rate Reconciliation at Federal Statutory Income Tax Rate, Amount USD 4.73M 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-12 0001193125-26-104258
us-gaap IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost Effective Income Tax Rate Reconciliation, Nondeductible Expense, Share-based Payment Arrangement, Amount USD -290,000 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-12 0001193125-26-104258
us-gaap IncomeTaxReconciliationOtherAdjustments Effective Income Tax Rate Reconciliation, Other Adjustments, Amount USD -59,000 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-12 0001193125-26-104258
us-gaap IncomeTaxReconciliationStateAndLocalIncomeTaxes Effective Income Tax Rate Reconciliation, State and Local Income Taxes, Amount USD 35,000 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-12 0001193125-26-104258
us-gaap IncomeTaxReconciliationTaxContingencies Effective Income Tax Rate Reconciliation, Tax Contingency, Amount USD -124,000 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-12 0001193125-26-104258
us-gaap IncomeTaxReconciliationTaxCreditsResearch Effective Income Tax Rate Reconciliation, Tax Credit, Research, Amount USD -360,000 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-12 0001193125-26-104258
us-gaap IncreaseDecreaseInAccountsPayableAndAccruedLiabilities Increase (Decrease) in Accounts Payable and Accrued Liabilities USD 2.49M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-13 0001193125-26-460950
us-gaap IncreaseDecreaseInAccountsReceivable Increase (Decrease) in Accounts Receivable USD 722,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-13 0001193125-26-460950
us-gaap IncreaseDecreaseInContractWithCustomerLiability Increase (Decrease) in Contract with Customer, Liability USD 0 2020-01-01 2020-12-31 2020 FY 10-K 2021-02-22 0001564590-21-007165
us-gaap IncreaseDecreaseInDeferredRevenue Increase (Decrease) in Deferred Revenue USD -1.64M 2023-01-01 2023-06-30 2023 Q2 10-Q 2023-08-14 0000950170-23-042363
us-gaap IncreaseDecreaseInInventories Increase (Decrease) in Inventories USD 0 2020-01-01 2020-12-31 2020 FY 10-K 2021-02-22 0001564590-21-007165
us-gaap IncreaseDecreaseInOperatingLeaseLiability IncreaseDecreaseInOperatingLeaseLiability USD -41,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-13 0001193125-26-460950
us-gaap IncreaseDecreaseInOtherCurrentAssets Increase (Decrease) in Other Current Assets USD 265,000 2025-01-01 2025-06-30 2025 Q2 10-Q 2025-08-14 0000950170-25-108874
us-gaap IncreaseDecreaseInOtherNoncurrentAssets Increase (Decrease) in Other Noncurrent Assets USD -218,000 2024-01-01 2024-12-31 2024 FY 10-K 2025-03-31 0000950170-25-047698
us-gaap IncreaseDecreaseInOtherNoncurrentLiabilities Increase (Decrease) in Other Noncurrent Liabilities USD 1.64M 2022-01-01 2022-12-31 2022 FY 10-K 2023-02-23 0000950170-23-004099
us-gaap IncreaseDecreaseInOtherOperatingAssets Increase (Decrease) in Other Operating Assets USD 864,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-13 0001193125-26-460950
us-gaap IncreaseDecreaseInOtherOperatingLiabilities Increase (Decrease) in Other Operating Liabilities USD -151,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-13 0001193125-26-460950
us-gaap IncreaseDecreaseInRestrictedCash Increase (Decrease) in Restricted Cash USD 325,000 2017-01-01 2017-12-31 2017 FY 10-K 2018-03-09 0001564590-18-005136
us-gaap IncreaseDecreaseInRestrictedCashAndInvestments Increase (Decrease) in Restricted Cash and Investments USD 0 2012-01-01 2012-12-31 2012 FY 10-K 2013-03-15 0001140361-13-012755
us-gaap IncrementalCommonSharesAttributableToCallOptionsAndWarrants Incremental Common Shares Attributable to Dilutive Effect of Call Options and Warrants shares 300,000 2015-07-01 2015-09-30 2016 Q3 10-Q 2016-11-09 0001564590-16-028714
us-gaap IntangibleAssetsArisingFromInsuranceContractsAcquiredInBusinessCombinationAmortizationExpenseNextTwelveMonths Intangible Assets Arising from Insurance Contracts Acquired in Business Combination, Amortization Expense, Next Twelve Months (Deprecated 2017-01-31) USD 782,000 2015-12-31 2015 FY 10-K 2016-03-11 0001140361-16-057505
us-gaap IntangibleAssetsArisingFromInsuranceContractsAcquiredInBusinessCombinationAmortizationExpenseYearFive Intangible Assets Arising from Insurance Contracts Acquired in Business Combination, Amortization Expense, Year Five (Deprecated 2017-01-31) USD 3.35M 2013-12-31 2013 FY 10-K 2014-03-14 0001140361-14-012811
us-gaap IntangibleAssetsArisingFromInsuranceContractsAcquiredInBusinessCombinationAmortizationExpenseYearFour Intangible Assets Arising from Insurance Contracts Acquired in Business Combination, Amortization Expense, Year Four (Deprecated 2017-01-31) USD 2.31M 2014-12-31 2014 FY 10-K 2015-03-16 0001140361-15-011947
us-gaap IntangibleAssetsArisingFromInsuranceContractsAcquiredInBusinessCombinationAmortizationExpenseYearThree Intangible Assets Arising from Insurance Contracts Acquired in Business Combination, Amortization Expense, Year Three (Deprecated 2017-01-31) USD 2.42M 2015-12-31 2015 FY 10-K 2016-03-11 0001140361-16-057505
us-gaap IntangibleAssetsArisingFromInsuranceContractsAcquiredInBusinessCombinationAmortizationExpenseYearTwo Intangible Assets Arising from Insurance Contracts Acquired in Business Combination, Amortization Expense, Year Two (Deprecated 2017-01-31) USD 1.54M 2015-12-31 2015 FY 10-K 2016-03-11 0001140361-16-057505
us-gaap IntangibleAssetsNetExcludingGoodwill Intangible Assets, Net (Excluding Goodwill) USD 5.96M 2018-12-31 8-K 2019-09-10 0001564590-19-034402
us-gaap IntangibleAssetsNetIncludingGoodwill Intangible Assets, Net (Including Goodwill) USD 9.88M 2018-12-31 2018 FY 10-K 2019-03-29 0001564590-19-010018
us-gaap InterestExpense Interest Expense USD 61,000 2024-01-01 2024-06-30 2024 Q2 10-Q 2024-08-14 0000950170-24-097091
us-gaap InterestExpenseNonoperating InterestExpenseNonoperating USD 36,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-13 0001193125-26-460950
us-gaap InterestPaid Interest Paid, Including Capitalized Interest, Operating and Investing Activities USD 311,000 2018-01-01 2018-03-31 2018 Q1 10-Q 2018-05-11 0001564590-18-013252
us-gaap InterestPaidNet Interest Paid, Excluding Capitalized Interest, Operating Activities USD 539,000 2025-01-01 2025-09-30 2026 Q3 10-Q 2026-11-13 0001193125-26-460950
us-gaap InterestPayableCurrent Interest Payable, Current USD 14,000 2026-09-30 2026 Q3 10-Q 2026-11-13 0001193125-26-460950
us-gaap InterestReceivableCurrent Interest Receivable, Current USD 40,000 2026-09-30 2026 Q3 10-Q 2026-11-13 0001193125-26-460950
us-gaap InventoryFinishedGoodsNetOfReserves Inventory, Finished Goods, Net of Reserves USD 1.68M 2019-03-31 2019 Q1 10-Q 2019-05-14 0001564590-19-019181
us-gaap InventoryNet Inventory, Net USD 235,000 2026-09-30 2026 Q3 10-Q 2026-11-13 0001193125-26-460950
us-gaap InventoryRawMaterialsNetOfReserves Inventory, Raw Materials, Net of Reserves USD 663,000 2019-03-31 2019 Q1 10-Q 2019-05-14 0001564590-19-019181
us-gaap InventoryWorkInProcessNetOfReserves Inventory, Work in Process, Net of Reserves USD 662,000 2019-03-31 2019 Q1 10-Q 2019-05-14 0001564590-19-019181
us-gaap InventoryWriteDown Inventory Write-down USD 0 2021-01-01 2021-12-31 2021 FY 10-K 2022-02-24 0001564590-22-006708
us-gaap InvestmentIncomeInterest Investment Income, Interest USD 365,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-13 0001193125-26-460950
us-gaap Investments Investments USD 4.60M 2025-06-30 2025 Q2 10-Q 2025-08-14 0000950170-25-108874
us-gaap LeaseCost Lease, Cost USD 62,000 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-12 0001193125-26-104258
us-gaap LeaseholdImprovementsGross Leasehold Improvements, Gross USD 1.81M 2025-12-31 2025 FY 10-K 2026-03-12 0001193125-26-104258
us-gaap LesseeOperatingLeaseDiscountRate Lessee, Operating Lease, Discount Rate pure 0.09 2021-09-30 2021 Q3 10-Q 2021-10-21 0001564590-21-051432
us-gaap LesseeOperatingLeaseLiabilityPaymentsDue Lessee, Operating Lease, Liability, to be Paid USD 77,000 2025-12-31 2025 FY 10-K 2026-03-12 0001193125-26-104258
us-gaap LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive Lessee, Operating Lease, Liability, to be Paid, after Year Five USD 234,000 2021-09-30 2021 Q3 10-Q 2021-10-21 0001564590-21-051432
us-gaap LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths Lessee, Operating Lease, Liability, to be Paid, Year One USD 62,000 2025-12-31 2025 FY 10-K 2026-03-12 0001193125-26-104258
us-gaap LesseeOperatingLeaseLiabilityPaymentsDueYearFive Lessee, Operating Lease, Liability, to be Paid, Year Five USD 108,000 2021-09-30 2021 Q3 10-Q 2021-10-21 0001564590-21-051432
us-gaap LesseeOperatingLeaseLiabilityPaymentsDueYearFour Lessee, Operating Lease, Liability, to be Paid, Year Four USD 18,000 2021-12-31 2021 FY 10-K 2022-02-24 0001564590-22-006708
us-gaap LesseeOperatingLeaseLiabilityPaymentsDueYearThree Lessee, Operating Lease, Liability, to be Paid, Year Three USD 11,000 2023-12-31 2023 FY 10-K 2024-03-05 0000950170-24-025851
us-gaap LesseeOperatingLeaseLiabilityPaymentsDueYearTwo Lessee, Operating Lease, Liability, to be Paid, Year Two USD 15,000 2025-12-31 2025 FY 10-K 2026-03-12 0001193125-26-104258
us-gaap LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear Lessee, Operating Lease, Liability, to be Paid, Remainder of Fiscal Year USD 103,000 2023-03-31 2023 Q1 10-Q 2023-04-20 0000950170-23-013671
us-gaap LesseeOperatingLeaseLiabilityUndiscountedExcessAmount Lessee, Operating Lease, Liability, Undiscounted Excess Amount USD 6,000 2025-12-31 2025 FY 10-K 2026-03-12 0001193125-26-104258
us-gaap LettersOfCreditOutstandingAmount Letters of Credit Outstanding, Amount USD 500,000 2017-12-31 2017 FY 10-K 2018-03-09 0001564590-18-005136
us-gaap Liabilities Liabilities USD 13.12M 2026-09-30 2026 Q3 10-Q 2026-11-13 0001193125-26-460950
us-gaap LiabilitiesAndStockholdersEquity Liabilities and Equity USD 12.20M 2026-09-30 2026 Q3 10-Q 2026-11-13 0001193125-26-460950
us-gaap LiabilitiesCurrent Liabilities, Current USD 13.12M 2026-09-30 2026 Q3 10-Q 2026-11-13 0001193125-26-460950
us-gaap LiabilitiesFairValueAdjustment Liabilities, Fair Value Adjustment USD 1,000 2022-01-01 2022-12-31 2023 FY 10-K 2024-03-05 0000950170-24-025851
us-gaap LiabilitiesOfBusinessTransferredUnderContractualArrangementCurrent Liabilities of Business Transferred under Contractual Arrangement, Current USD 1.80M 2015-12-31 2015 FY 10-K 2016-03-11 0001140361-16-057505
us-gaap LiabilitiesOfDisposalGroupIncludingDiscontinuedOperation Disposal Group, Including Discontinued Operation, Liabilities USD 0 2020-12-31 2020 FY 10-K 2021-02-22 0001564590-21-007165
us-gaap LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent Disposal Group, Including Discontinued Operation, Liabilities, Current USD 580,000 2018-12-31 2019 FY 10-K 2020-03-30 0001564590-20-014165
us-gaap LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationNoncurrent Disposal Group, Including Discontinued Operation, Liabilities, Noncurrent USD 245,000 2018-12-31 2019 FY 10-K 2020-03-30 0001564590-20-014165
us-gaap LiabilityForUncertainTaxPositionsCurrent Liability for Uncertainty in Income Taxes, Current USD 0 2025-12-31 2025 FY 10-K 2026-03-12 0001193125-26-104258
us-gaap LinesOfCreditCurrent Line of Credit, Current USD 0 2026-09-30 2026 Q3 10-Q 2026-11-13 0001193125-26-460950
us-gaap LongTermDebtAndCapitalLeaseObligations Long-term Debt and Lease Obligation USD 0 2017-12-31 2017 FY 10-K 2018-03-09 0001564590-18-005136
us-gaap LongTermDebtAndCapitalLeaseObligationsIncludingCurrentMaturities Long-term Debt and Lease Obligation, Including Current Maturities USD 5.39M 2022-12-31 2022 FY 10-K 2023-02-23 0000950170-23-004099
us-gaap LongTermDebtCurrent Long-term Debt, Current Maturities USD 3.98M 2023-12-31 2024 FY 10-K 2025-03-31 0000950170-25-047698
us-gaap LongTermDebtNoncurrent Long-term Debt, Excluding Current Maturities USD 3.79M 2022-12-31 2023 FY 10-K 2024-03-05 0000950170-24-025851
us-gaap MachineryAndEquipmentGross Machinery and Equipment, Gross USD 3.75M 2018-12-31 2018 FY 10-K 2019-03-29 0001564590-19-010018
us-gaap NetCashProvidedByUsedInFinancingActivities Net Cash Provided by (Used in) Financing Activities USD 14.33M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-13 0001193125-26-460950
us-gaap NetCashProvidedByUsedInFinancingActivitiesContinuingOperations Net Cash Provided by (Used in) Financing Activities, Continuing Operations USD -150,000 2018-01-01 2018-03-31 2018 Q1 10-Q 2018-05-11 0001564590-18-013252
us-gaap NetCashProvidedByUsedInInvestingActivities Net Cash Provided by (Used in) Investing Activities USD -1.17M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-13 0001193125-26-460950
us-gaap NetCashProvidedByUsedInInvestingActivitiesContinuingOperations Net Cash Provided by (Used in) Investing Activities, Continuing Operations USD -53,000 2018-01-01 2018-03-31 2018 Q1 10-Q 2018-05-11 0001564590-18-013252
us-gaap NetCashProvidedByUsedInOperatingActivities Net Cash Provided by (Used in) Operating Activities USD -21.04M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-13 0001193125-26-460950
us-gaap NetCashProvidedByUsedInOperatingActivitiesContinuingOperations Net Cash Provided by (Used in) Operating Activities, Continuing Operations USD -4.12M 2018-01-01 2018-03-31 2018 Q1 10-Q 2018-05-11 0001564590-18-013252
us-gaap NetIncomeLoss Net Income (Loss) Attributable to Parent USD -24.61M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-13 0001193125-26-460950
us-gaap NetIncomeLossAvailableToCommonStockholdersBasic Net Income (Loss) Available to Common Stockholders, Basic USD -15.95M 2026-01-01 2026-06-30 2026 Q2 10-Q 2026-08-14 0001193125-26-352444
us-gaap NetIncomeLossAvailableToCommonStockholdersDiluted Net Income (Loss) Available to Common Stockholders, Diluted USD -15.95M 2026-01-01 2026-06-30 2026 Q2 10-Q 2026-08-14 0001193125-26-352444
us-gaap NetIncomeLossFromContinuingOperationsAvailableToCommonShareholdersBasic Net Income (Loss) from Continuing Operations Available to Common Shareholders, Basic USD -8.24M 2020-01-01 2020-12-31 2020 FY 10-K 2021-02-22 0001564590-21-007165
us-gaap NetIncomeLossFromDiscontinuedOperationsAvailableToCommonShareholdersBasic Net Income (Loss) from Discontinued Operations Available to Common Shareholders, Basic USD 0 2020-01-01 2020-12-31 2020 FY 10-K 2021-02-22 0001564590-21-007165
us-gaap NewAccountingPronouncementOrChangeInAccountingPrincipleCumulativeEffectOfChangeOnEquityOrNetAssets New Accounting Pronouncement or Change in Accounting Principle, Cumulative Effect of Change on Equity or Net Assets (Deprecated 2012-01-31) USD -1.70M 2009-01-01 2009-12-31 2011 FY 10-K/A 2012-09-07 0001140361-12-039821
us-gaap NoncashOrPartNoncashAcquisitionFixedAssetsAcquired1 Noncash or Part Noncash Acquisition, Fixed Assets Acquired USD 795,000 2012-01-01 2012-03-31 2012 Q1 10-Q 2012-05-10 0001140361-12-024098
us-gaap NonoperatingIncomeExpense Nonoperating Income (Expense) USD -978,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-13 0001193125-26-460950
us-gaap NumberOfOperatingSegments Number of Operating Segments Segment 2 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-13 0001193125-26-460950
us-gaap NumberOfReportableSegments Number of Reportable Segments Segment 2 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-13 0001193125-26-460950
us-gaap NumberOfReportingUnits Number of Reporting Units ReportableUnit 1 2024-01-01 2024-12-31 2024 FY 10-K 2025-03-31 0000950170-25-047698
us-gaap OperatingExpenses Operating Expenses USD 25.79M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-13 0001193125-26-460950
us-gaap OperatingIncomeLoss Operating Income (Loss) USD -23.63M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-13 0001193125-26-460950
us-gaap OperatingLeaseCost Operating Lease, Cost USD 62,000 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-12 0001193125-26-104258
us-gaap OperatingLeaseExpense Operating Lease, Expense USD 400,000 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-12 0001193125-26-104258
us-gaap OperatingLeaseLiability Operating Lease, Liability USD 71,000 2025-12-31 2025 FY 10-K 2026-03-12 0001193125-26-104258
us-gaap OperatingLeaseLiabilityCurrent Operating Lease, Liability, Current USD 30,000 2026-09-30 2026 Q3 10-Q 2026-11-13 0001193125-26-460950
us-gaap OperatingLeaseLiabilityNoncurrent Operating Lease, Liability, Noncurrent USD 15,000 2025-12-31 2026 Q3 10-Q 2026-11-13 0001193125-26-460950
us-gaap OperatingLeasePayments Operating Lease, Payments USD 59,000 2026-08-10 2026 Q3 10-Q 2026-11-13 0001193125-26-460950
us-gaap OperatingLeaseRightOfUseAsset Operating Lease, Right-of-Use Asset USD 29,000 2026-09-30 2026 Q3 10-Q 2026-11-13 0001193125-26-460950
us-gaap OperatingLeaseRightOfUseAssetAmortizationExpense Operating Lease, Right-of-Use Asset, Amortization Expense USD 41,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-13 0001193125-26-460950
us-gaap OperatingLeasesFutureMinimumPaymentsDue Operating Leases, Future Minimum Payments Due USD 4.11M 2015-12-31 2015 FY 10-K 2016-03-11 0001140361-16-057505
us-gaap OperatingLeasesFutureMinimumPaymentsDueCurrent Operating Leases, Future Minimum Payments Due, Next Twelve Months USD 2.24M 2015-12-31 2015 FY 10-K 2016-03-11 0001140361-16-057505
us-gaap OperatingLeasesFutureMinimumPaymentsDueInFiveYears Operating Leases, Future Minimum Payments, Due in Five Years USD 27,000 2014-12-31 2014 FY 10-K 2015-03-16 0001140361-15-011947
us-gaap OperatingLeasesFutureMinimumPaymentsDueInFourYears Operating Leases, Future Minimum Payments, Due in Four Years USD 27,000 2015-12-31 2015 FY 10-K 2016-03-11 0001140361-16-057505
us-gaap OperatingLeasesFutureMinimumPaymentsDueInThreeYears Operating Leases, Future Minimum Payments, Due in Three Years USD 53,000 2015-12-31 2015 FY 10-K 2016-03-11 0001140361-16-057505
us-gaap OperatingLeasesFutureMinimumPaymentsDueInTwoYears Operating Leases, Future Minimum Payments, Due in Two Years USD 1.79M 2015-12-31 2015 FY 10-K 2016-03-11 0001140361-16-057505
us-gaap OperatingLeasesFutureMinimumPaymentsDueThereafter Operating Leases, Future Minimum Payments, Due Thereafter USD 1.59M 2012-12-31 2012 FY 10-K 2013-03-15 0001140361-13-012755
us-gaap OperatingLeasesRentExpenseNet Operating Leases, Rent Expense, Net USD 170,000 2021-01-01 2021-09-30 2021 Q3 10-Q 2021-10-21 0001564590-21-051432
us-gaap OperatingLeaseWeightedAverageDiscountRatePercent Operating Lease, Weighted Average Discount Rate, Percent pure 0.127 2025-12-31 2025 FY 10-K 2026-03-12 0001193125-26-104258
us-gaap OtherAccruedLiabilitiesCurrent Other Accrued Liabilities, Current USD 935,000 2025-12-31 2025 FY 10-K 2026-03-12 0001193125-26-104258
us-gaap OtherAssets Other Assets USD 39,000 2018-12-31 8-K 2019-09-10 0001564590-19-034402
us-gaap OtherAssetsCurrent Other Assets, Current USD 2.24M 2026-09-30 2026 Q3 10-Q 2026-11-13 0001193125-26-460950
us-gaap OtherAssetsNoncurrent Other Assets, Noncurrent USD 391,000 2026-09-30 2026 Q3 10-Q 2026-11-13 0001193125-26-460950
us-gaap OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Adjustment, Net of Tax USD -140,000 2019-01-01 2019-03-31 2020 Q1 10-Q 2020-05-14 0001564590-20-025453
us-gaap OtherComprehensiveIncomeLossNetOfTax Other Comprehensive Income (Loss), Net of Tax USD 296,000 2015-01-01 2015-12-31 2015 FY 10-K 2016-03-11 0001140361-16-057505
us-gaap OtherDeferredCostsNet Other Deferred Costs, Net USD 855,000 2026-09-30 2026 Q3 10-Q 2026-11-13 0001193125-26-460950
us-gaap OtherIntangibleAssetsNet Other Intangible Assets, Net USD 231,000 2026-09-30 2026 Q3 10-Q 2026-11-13 0001193125-26-460950
us-gaap OtherLiabilitiesCurrent Other Liabilities, Current USD 105,000 2026-09-30 2026 Q3 10-Q 2026-11-13 0001193125-26-460950
us-gaap OtherLiabilitiesNoncurrent Other Liabilities, Noncurrent USD 8,000 2019-12-31 2020 FY 10-K 2021-02-22 0001564590-21-007165
us-gaap OtherNonoperatingExpense Other Nonoperating Expense USD 179,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-13 0001193125-26-460950
us-gaap OtherNonoperatingIncomeExpense Other Nonoperating Income (Expense) USD 149,000 2019-01-01 2019-03-31 2019 Q1 10-Q 2019-05-14 0001564590-19-019181
us-gaap OtherPrepaidExpenseCurrent Other Prepaid Expense, Current USD 1.05M 2026-09-30 2026 Q3 10-Q 2026-11-13 0001193125-26-460950
us-gaap OtherReceivables Other Receivables USD 144,000 2019-12-31 2019 FY 10-K 2020-03-30 0001564590-20-014165
us-gaap OtherSignificantNoncashTransactionValueOfConsiderationGiven1 Other Significant Noncash Transaction, Value of Consideration Given USD 0 2016-01-01 2016-12-31 2016 FY 10-K 2017-03-24 0001564590-17-005251
us-gaap PaymentOfFinancingAndStockIssuanceCosts Payment of Financing and Stock Issuance Costs USD 1.53M 2018-01-01 2018-12-31 8-K 2019-09-10 0001564590-19-034402
us-gaap PaymentsForPreviousAcquisition Payments for Previous Acquisition USD 2.80M 2015-01-01 2015-03-31 2015 Q1 10-Q 2015-05-11 0001140361-15-018816
us-gaap PaymentsForProceedsFromPreviousAcquisition Payments for (Proceeds from) Previous Acquisition USD 3.20M 2015-01-01 2015-03-31 2015 Q1 10-Q 2015-05-11 0001140361-15-018816
us-gaap PaymentsForRepurchaseOfEquity Payments for Repurchase of Equity USD 374,000 2024-01-01 2024-12-31 2025 FY 10-K 2026-03-12 0001193125-26-104258
us-gaap PaymentsOfDividendsPreferredStockAndPreferenceStock Payments of Ordinary Dividends, Preferred Stock and Preference Stock USD 0 2016-01-01 2016-12-31 2016 FY 10-K 2017-03-24 0001564590-17-005251
us-gaap PaymentsOfFinancingCosts Payments of Financing Costs USD 2.25M 2025-01-01 2025-09-30 2026 Q3 10-Q 2026-11-13 0001193125-26-460950
us-gaap PaymentsOfStockIssuanceCosts Payments of Stock Issuance Costs USD 1.36M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-13 0001193125-26-460950
us-gaap PaymentsToAcquireIntangibleAssets Payments to Acquire Intangible Assets USD 7,000 2025-01-01 2025-09-30 2026 Q3 10-Q 2026-11-13 0001193125-26-460950
us-gaap PaymentsToAcquireInterestInJointVenture Payments to Acquire Interest in Joint Venture USD 0 2017-01-01 2017-12-31 2017 FY 10-K 2018-03-09 0001564590-18-005136
us-gaap PaymentsToAcquirePropertyPlantAndEquipment Payments to Acquire Property, Plant, and Equipment USD 1.37M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-13 0001193125-26-460950
us-gaap PaymentsToAcquireShortTermInvestments Payments to Acquire Short-term Investments USD 15.09M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-13 0001193125-26-460950
us-gaap PreferredStockDividendRatePercentage Preferred Stock, Dividend Rate, Percentage pure 0.036 2017-01-01 2017-09-30 2017 Q3 10-Q 2017-11-09 0001564590-17-023317
us-gaap PreferredStockDividendsAndOtherAdjustments Preferred Stock Dividends and Other Adjustments USD 0 2020-01-01 2020-12-31 2020 FY 10-K 2021-02-22 0001564590-21-007165
us-gaap PreferredStockParOrStatedValuePerShare Preferred Stock, Par or Stated Value Per Share USD/shares 0.001 2026-09-30 2026 Q3 10-Q 2026-11-13 0001193125-26-460950
us-gaap PreferredStockSharesAuthorized Preferred Stock, Shares Authorized shares 5.00M 2026-09-30 2026 Q3 10-Q 2026-11-13 0001193125-26-460950
us-gaap PreferredStockSharesIssued Preferred Stock, Shares Issued shares 1,952 2026-09-30 2026 Q3 10-Q 2026-11-13 0001193125-26-460950
us-gaap PreferredStockSharesOutstanding Preferred Stock, Shares Outstanding shares 1,952 2026-09-30 2026 Q3 10-Q 2026-11-13 0001193125-26-460950
us-gaap PreferredStockValue Preferred Stock, Value, Issued USD 0 2017-12-31 2017 FY 10-K 2018-03-09 0001564590-18-005136
us-gaap PrepaidInsurance Prepaid Insurance USD 150,000 2026-09-30 2026 Q3 10-Q 2026-11-13 0001193125-26-460950
us-gaap PrepaidTaxes Prepaid Taxes USD 19,000 2018-12-31 2018 FY 10-K 2019-03-29 0001564590-19-010018
us-gaap ProceedsFromDivestitureOfBusinesses Proceeds from Divestiture of Businesses USD 0 2020-01-01 2020-12-31 2020 FY 10-K 2021-02-22 0001564590-21-007165
us-gaap ProceedsFromIssuanceInitialPublicOffering Proceeds from Issuance Initial Public Offering USD 13.20M 2019-09-01 2019-09-30 2019 Q3 10-Q 2019-11-14 0001564590-19-043516
us-gaap ProceedsFromIssuanceOfCommonStock Proceeds from Issuance of Common Stock USD 19.61M 2025-01-01 2025-09-30 2026 Q3 10-Q 2026-11-13 0001193125-26-460950
us-gaap ProceedsFromIssuanceOfLongTermDebt Proceeds from Issuance of Long-term Debt USD 0 2016-01-01 2016-12-31 2016 FY 10-K 2017-03-24 0001564590-17-005251
us-gaap ProceedsFromIssuanceOfPreferredStockAndPreferenceStock Proceeds from Issuance of Preferred Stock and Preference Stock USD 0 2015-01-01 2015-12-31 2015 FY 10-K 2016-03-11 0001140361-16-057505
us-gaap ProceedsFromIssuanceOfPrivatePlacement Proceeds from Issuance of Private Placement USD 7.30M 2024-05-09 2024 Q3 10-Q 2024-11-14 0000950170-24-127014
us-gaap ProceedsFromIssuanceOrSaleOfEquity Proceeds from Issuance or Sale of Equity USD 7.26M 2024-01-01 2024-12-31 2024 FY 10-K 2025-03-31 0000950170-25-047698
us-gaap ProceedsFromLinesOfCredit Proceeds from Lines of Credit USD 1.00M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-13 0001193125-26-460950
us-gaap ProceedsFromSaleOfProductiveAssets Proceeds from Sale of Productive Assets USD 0 2018-01-01 2018-12-31 8-K 2019-09-10 0001564590-19-034402
us-gaap ProceedsFromSaleOfPropertyPlantAndEquipment Proceeds from Sale of Property, Plant, and Equipment USD 30,000 2025-01-01 2025-09-30 2026 Q3 10-Q 2026-11-13 0001193125-26-460950
us-gaap ProceedsFromSaleOfShortTermInvestments Proceeds from Sale of Short-term Investments USD 10.69M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-13 0001193125-26-460950
us-gaap ProceedsFromSaleOfTreasuryStock Proceeds from Sale of Treasury Stock USD 0 2011-01-01 2011-12-31 2011 FY 10-K/A 2012-09-07 0001140361-12-039821
us-gaap ProceedsFromStockOptionsExercised Proceeds from Stock Options Exercised USD 0 2016-01-01 2016-12-31 2016 FY 10-K 2017-03-24 0001564590-17-005251
us-gaap ProceedsFromWarrantExercises Proceeds from Warrant Exercises USD 882,000 2025-01-01 2025-06-30 2026 Q2 10-Q 2026-08-14 0001193125-26-352444
us-gaap ProductWarrantyExpense Product Warranty Expense USD 0 2011-01-01 2011-12-31 2011 FY 10-K/A 2012-09-07 0001140361-12-039821
us-gaap PropertyPlantAndEquipmentGross Property, Plant and Equipment, Gross USD 3.59M 2025-12-31 2025 FY 10-K 2026-03-12 0001193125-26-104258
us-gaap PropertyPlantAndEquipmentNet Property, Plant and Equipment, Net USD 1.35M 2026-09-30 2026 Q3 10-Q 2026-11-13 0001193125-26-460950
us-gaap ProvisionForDoubtfulAccounts Accounts Receivable, Credit Loss Expense (Reversal) USD 0 2019-01-01 2019-12-31 2019 FY 10-K 2020-03-30 0001564590-20-014165
us-gaap PurchaseObligation Purchase Obligation USD 4.02M 2017-12-31 2017 FY 10-K 2018-03-09 0001564590-18-005136
us-gaap PurchaseObligationDueInFifthYear Purchase Obligation, to be Paid, Year Five USD 1.47M 2016-12-31 2016 FY 10-K 2017-03-24 0001564590-17-005251
us-gaap PurchaseObligationDueInFourthYear Purchase Obligation, to be Paid, Year Four USD 1.47M 2016-12-31 2016 FY 10-K 2017-03-24 0001564590-17-005251
us-gaap PurchaseObligationDueInNextTwelveMonths Purchase Obligation, to be Paid, Year One USD 1.07M 2017-12-31 2017 FY 10-K 2018-03-09 0001564590-18-005136
us-gaap PurchaseObligationDueInSecondYear Purchase Obligation, to be Paid, Year Two USD 1.47M 2017-12-31 2017 FY 10-K 2018-03-09 0001564590-18-005136
us-gaap PurchaseObligationDueInThirdYear Purchase Obligation, to be Paid, Year Three USD 1.47M 2017-12-31 2017 FY 10-K 2018-03-09 0001564590-18-005136
us-gaap PurchaseObligationFutureMinimumPaymentsRemainderOfFiscalYear Purchase Obligation, to be Paid, Remainder of Fiscal Year USD 0 2016-12-31 2016 FY 10-K 2017-03-24 0001564590-17-005251
us-gaap RecordedUnconditionalPurchaseObligationDueWithinOneYear Recorded Unconditional Purchase Obligation, to be Paid, Year One USD 1.00M 2015-09-30 2015 Q3 10-Q 2015-11-06 0001140361-15-040028
us-gaap RelatedPartyTransactionRevenuesFromTransactionsWithRelatedParty Related Party Transaction, Revenues from Transactions with Related Party (Deprecated 2012-01-31) USD 0 2011-01-01 2011-12-31 2011 FY 10-K/A 2012-09-07 0001140361-12-039821
us-gaap RepaymentsOfLinesOfCredit Repayments of Lines of Credit USD 1.77M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-13 0001193125-26-460950
us-gaap RepaymentsOfLongTermDebt Repayments of Long-term Debt USD 4.00M 2024-01-01 2024-12-31 2025 FY 10-K 2026-03-12 0001193125-26-104258
us-gaap RepaymentsOfNotesPayable Repayments of Notes Payable USD 3.70M 2025-01-01 2025-09-30 2026 Q3 10-Q 2026-11-13 0001193125-26-460950
us-gaap ResearchAndDevelopmentArrangementWithFederalGovernmentCustomerFundingToOffsetCostsIncurred Research and Development Arrangement with Federal Government, Customer Funding to Offset Costs Incurred USD 4.70M 2012-07-01 2012-09-30 2012 Q3 10-Q 2012-11-09 0001140361-12-046470
us-gaap ResearchAndDevelopmentAssetAcquiredOtherThanThroughBusinessCombinationWrittenOff Research and Development Asset Acquired Other than Through Business Combination, Written-off USD 0 2018-01-01 2018-12-31 8-K 2019-09-10 0001564590-19-034402
us-gaap ResearchAndDevelopmentExpense Research and Development Expense USD 9.24M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-13 0001193125-26-460950
us-gaap ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost Research and Development Expense (Excluding Acquired in Process Cost) USD 9.70M 2022-01-01 2022-12-31 2022 FY 10-K 2023-02-23 0000950170-23-004099
us-gaap ResearchAndDevelopmentInProcess Research and Development in Process USD 0 2022-01-01 2022-12-31 2022 FY 10-K 2023-02-23 0000950170-23-004099
us-gaap RestrictedCash Restricted Cash USD 0 2020-12-31 2020 FY 10-K 2021-02-22 0001564590-21-007165
us-gaap RestrictedCashAndCashEquivalentsAtCarryingValue Restricted Cash and Cash Equivalents, Current USD 4.50M 2025-12-31 2026 Q3 10-Q 2026-11-13 0001193125-26-460950
us-gaap RestrictedCashAndCashEquivalentsNoncurrent Restricted Cash and Cash Equivalents, Noncurrent USD 0 2016-12-31 2016 FY 10-K 2017-03-24 0001564590-17-005251
us-gaap RetainedEarningsAccumulatedDeficit Retained Earnings (Accumulated Deficit) USD -540.47M 2026-09-30 2026 Q3 10-Q 2026-11-13 0001193125-26-460950
us-gaap RevenueFromContractWithCustomerExcludingAssessedTax Revenue from Contract with Customer, Excluding Assessed Tax USD 703,000 2019-01-01 2019-03-31 2019 Q1 10-Q 2019-05-14 0001564590-19-019181
us-gaap RevenueFromContractWithCustomerIncludingAssessedTax Revenue from Contract with Customer, Including Assessed Tax USD 1.00M 2018-01-01 2018-12-31 8-K 2019-09-10 0001564590-19-034402
us-gaap RevenueFromRelatedParties Revenue from Related Parties USD 0 2015-01-01 2015-12-31 2015 FY 10-K 2016-03-11 0001140361-16-057505
us-gaap Revenues Revenues USD 2.16M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-13 0001193125-26-460950
us-gaap RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability Right-of-Use Asset Obtained in Exchange for Finance Lease Liability USD 71,000 2023-01-01 2023-09-30 2024 Q3 10-Q 2024-11-14 0000950170-24-127014
us-gaap RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability Right-of-Use Asset Obtained in Exchange for Operating Lease Liability USD 62,000 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-12 0001193125-26-104258
us-gaap RoyaltyExpense Royalty Expense USD 232,000 2012-01-01 2012-12-31 2012 FY 10-K 2013-03-15 0001140361-13-012755
us-gaap SaleOfStockPricePerShare Sale of Stock, Price Per Share USD/shares 5 2020-06-30 2020 Q2 10-Q 2020-08-10 0001564590-20-038551
us-gaap SalesRevenueGoodsNet Sales Revenue, Goods, Net (Deprecated 2018-01-31) USD 4.84M 2015-01-01 2015-12-31 2015 FY 10-K 2016-03-11 0001140361-16-057505
us-gaap SecurityDeposit Security Deposit USD 0 2020-12-31 2020 FY 10-K 2021-02-22 0001564590-21-007165
us-gaap SellingAndMarketingExpense Selling and Marketing Expense USD 319,000 2020-01-01 2020-09-30 2020 Q3 10-Q 2020-10-22 0001564590-20-047266
us-gaap SellingGeneralAndAdministrativeExpense Selling, General and Administrative Expense USD 15.64M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-13 0001193125-26-460950
us-gaap ShareBasedCompensation Share-based Payment Arrangement, Noncash Expense USD 2.56M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-13 0001193125-26-460950
us-gaap SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage Share-based Compensation Arrangement by Share-based Payment Award, Award Vesting Rights, Percentage pure 0.25 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-13 0001193125-26-460950
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Dividend Rate pure 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-12 0001193125-26-104258
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate pure 0.039 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-12 0001193125-26-104258
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageExpectedDividend Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Weighted Average Expected Dividend USD 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-12 0001193125-26-104258
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Weighted Average Volatility Rate pure 1.496 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-12 0001193125-26-104258
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant Share-based Compensation Arrangement by Share-based Payment Award, Number of Shares Available for Grant shares 97,866 2019-12-31 2019 FY 10-K 2020-03-30 0001564590-20-014165
us-gaap SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1 Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Intrinsic Value USD 0 2026-09-30 2026 Q3 10-Q 2026-11-13 0001193125-26-460950
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Number shares 197,491 2026-09-30 2026 Q3 10-Q 2026-11-13 0001193125-26-460950
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Weighted Average Exercise Price USD/shares 27.17 2026-09-30 2026 Q3 10-Q 2026-11-13 0001193125-26-460950
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period, Intrinsic Value USD 0 2015-01-01 2015-12-31 2015 FY 10-K 2016-03-11 0001140361-16-057505
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod Share-based Compensation Arrangement by Share-based Payment Award, Options, Expirations in Period shares 37 2019-01-01 2019-12-31 2019 FY 10-K 2020-03-30 0001564590-20-014165
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures in Period shares 34,979 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-13 0001193125-26-460950
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross shares 235,639 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-13 0001193125-26-460950
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value USD/shares 0.57 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-12 0001193125-26-104258
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Intrinsic Value USD 0 2026-09-30 2026 Q3 10-Q 2026-11-13 0001193125-26-460950
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Number shares 666,497 2026-09-30 2026 Q3 10-Q 2026-11-13 0001193125-26-460950
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price USD/shares 16.35 2026-09-30 2026 Q3 10-Q 2026-11-13 0001193125-26-460950
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Exercisable, Aggregate Intrinsic Value USD 0 2023-09-30 2023 Q3 10-Q 2023-10-31 0000950170-23-056844
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Exercisable, Number shares 65,008 2023-09-30 2023 Q3 10-Q 2023-10-31 0000950170-23-056844
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Exercisable, Weighted Average Exercise Price USD/shares 16.35 2026-09-30 2026 Q3 10-Q 2026-11-13 0001193125-26-460950
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Aggregate Intrinsic Value USD 0 2026-09-30 2026 Q3 10-Q 2026-11-13 0001193125-26-460950
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Number shares 666,497 2026-09-30 2026 Q3 10-Q 2026-11-13 0001193125-26-460950
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Weighted Average Exercise Price USD/shares 38.83 2023-09-30 2023 Q3 10-Q 2023-10-31 0000950170-23-056844
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedInPeriodFairValue Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested in Period, Fair Value (Deprecated 2013-01-31) USD 4.72M 2013-01-01 2013-12-31 2013 FY 10-K 2014-03-14 0001140361-14-012811
us-gaap SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1 Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested in Period, Fair Value USD 2.36M 2015-01-01 2015-12-31 2015 FY 10-K 2016-03-11 0001140361-16-057505
us-gaap ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice Share-based Compensation Arrangements by Share-based Payment Award, Options, Exercises in Period, Weighted Average Exercise Price USD/shares 0 2015-01-01 2015-12-31 2015 FY 10-K 2016-03-11 0001140361-16-057505
us-gaap ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice Share-based Compensation Arrangements by Share-based Payment Award, Options, Expirations in Period, Weighted Average Exercise Price USD/shares 41,692 2019-01-01 2019-12-31 2019 FY 10-K 2020-03-30 0001564590-20-014165
us-gaap ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice Share-based Compensation Arrangements by Share-based Payment Award, Options, Forfeitures in Period, Weighted Average Exercise Price USD/shares 18.55 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-13 0001193125-26-460950
us-gaap ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice Share-based Compensation Arrangements by Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price USD/shares 6.67 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-13 0001193125-26-460950
us-gaap SharePrice Share Price USD/shares 2.25 2020-03-31 2020 Q1 10-Q 2020-05-14 0001564590-20-025453
us-gaap ShortTermInvestments Short-term Investments USD 3.99M 2026-09-30 2026 Q3 10-Q 2026-11-13 0001193125-26-460950
us-gaap StockholdersEquity Stockholders' Equity Attributable to Parent USD -923,000 2026-09-30 2026 Q3 10-Q 2026-11-13 0001193125-26-460950
us-gaap StockholdersEquityNoteStockSplitConversionRatio1 Stockholders' Equity Note, Stock Split, Conversion Ratio pure 0.04 2026-04-01 2026 Q3 10-Q 2026-11-13 0001193125-26-460950
us-gaap StockIssued1 Stock Issued USD 75,000 2023-01-01 2023-12-31 2024 FY 10-K 2025-03-31 0000950170-25-047698
us-gaap StockIssuedDuringPeriodSharesNewIssues Stock Issued During Period, Shares, New Issues shares 3.45M 2020-01-01 2020-06-30 2020 Q2 10-Q 2020-08-10 0001564590-20-038551
us-gaap StockIssuedDuringPeriodSharesReverseStockSplits Stock Issued During Period, Shares, Reverse Stock Splits shares 1,310 2024-01-01 2024-06-30 2024 Q2 10-Q 2024-08-14 0000950170-24-097091
us-gaap StockIssuedDuringPeriodSharesStockOptionsExercised Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period shares 0 2015-01-01 2015-12-31 2015 FY 10-K 2016-03-11 0001140361-16-057505
us-gaap StockIssuedDuringPeriodSharesStockSplits Stock Issued During Period, Shares, Stock Splits shares 0 2024-01-01 2024-06-30 2024 Q2 10-Q 2024-08-14 0000950170-24-097091
us-gaap StockIssuedDuringPeriodValueAcquisitions Stock Issued During Period, Value, Acquisitions USD 381,000 2020-01-01 2020-12-31 2021 FY 10-K 2022-02-24 0001564590-22-006708
us-gaap StockIssuedDuringPeriodValueConversionOfConvertibleSecurities Stock Issued During Period, Value, Conversion of Convertible Securities USD -2,000 2015-01-01 2015-12-31 2016 FY 10-K 2017-03-24 0001564590-17-005251
us-gaap StockIssuedDuringPeriodValueEmployeeStockPurchasePlan Stock Issued During Period, Value, Employee Stock Purchase Plan USD 1,000 2017-01-01 2017-12-31 8-K 2019-09-10 0001564590-19-034402
us-gaap StockIssuedDuringPeriodValueIssuedForServices Stock Issued During Period, Value, Issued for Services USD 75,000 2023-01-01 2023-12-31 2024 FY 10-K 2025-03-31 0000950170-25-047698
us-gaap StockIssuedDuringPeriodValueNewIssues Stock Issued During Period, Value, New Issues USD 13.89M 2026-01-01 2026-03-31 2026 Q3 10-Q 2026-11-13 0001193125-26-460950
us-gaap StockIssuedDuringPeriodValueOther Stock Issued During Period, Value, Other USD 22.81M 2015-01-01 2015-12-31 2016 FY 10-K 2017-03-24 0001564590-17-005251
us-gaap StockIssuedDuringPeriodValueShareBasedCompensationGross Shares Issued, Value, Share-based Payment Arrangement, before Forfeiture USD 27,000 2015-01-01 2015-12-31 2016 FY 10-K 2017-03-24 0001564590-17-005251
us-gaap StockIssuedDuringPeriodValueStockOptionsExercised Stock Issued During Period, Value, Stock Options Exercised USD 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-12 0001193125-26-104258
us-gaap StockIssuedDuringPeriodValueTreasuryStockReissued Stock Issued During Period, Value, Treasury Stock Reissued USD 3.93M 2009-01-01 2009-12-31 2011 FY 10-K/A 2012-09-07 0001140361-12-039821
us-gaap StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1 Stock Repurchase Program, Remaining Authorized Repurchase Amount USD 0 2024-12-31 2025 FY 10-K 2026-03-12 0001193125-26-104258
us-gaap Supplies Prepaid Supplies USD 1.54M 2018-12-31 2018 FY 10-K 2019-03-29 0001564590-19-010018
us-gaap TaxCutsAndJobsActOf2017ChangeInTaxRateIncomeTaxExpenseBenefit Tax Cuts and Jobs Act, Change in Tax Rate, Income Tax Expense (Benefit) USD 45.80M 2017-01-01 2017-12-31 8-K 2019-09-10 0001564590-19-034402
us-gaap TreasuryStockCommonShares Treasury Stock, Common, Shares shares 10,337 2026-09-30 2026 Q3 10-Q 2026-11-13 0001193125-26-460950
us-gaap TreasuryStockCommonValue Treasury Stock, Common, Value USD 500,000 2026-09-30 2026 Q3 10-Q 2026-11-13 0001193125-26-460950
us-gaap TreasuryStockValueAcquiredCostMethod Treasury Stock, Value, Acquired, Cost Method USD 374,000 2024-01-01 2024-12-31 2025 FY 10-K 2026-03-12 0001193125-26-104258
us-gaap UndistributedEarningsLossAvailableToCommonShareholdersDiluted Undistributed Earnings (Loss) Available to Common Shareholders, Diluted USD -15.95M 2026-01-01 2026-06-30 2026 Q2 10-Q 2026-08-14 0001193125-26-352444
us-gaap UnrecognizedTaxBenefits Unrecognized Tax Benefits USD 557,000 2025-12-31 2025 FY 10-K 2026-03-12 0001193125-26-104258
us-gaap UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions Unrecognized Tax Benefits, Decrease Resulting from Prior Period Tax Positions USD 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-12 0001193125-26-104258
us-gaap UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense Unrecognized Tax Benefits, Income Tax Penalties and Interest Expense USD 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-12 0001193125-26-104258
us-gaap UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions Unrecognized Tax Benefits, Increase Resulting from Current Period Tax Positions USD 128,000 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-12 0001193125-26-104258
us-gaap UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions Unrecognized Tax Benefits, Increase Resulting from Prior Period Tax Positions USD 5,000 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-12 0001193125-26-104258
us-gaap UnrecognizedTaxBenefitsIncreasesResultingFromSettlementsWithTaxingAuthorities Unrecognized Tax Benefits, Increase Resulting from Settlements with Taxing Authorities USD 0 2015-01-01 2015-12-31 2015 FY 10-K 2016-03-11 0001140361-16-057505
us-gaap UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations Unrecognized Tax Benefits, Reduction Resulting from Lapse of Applicable Statute of Limitations USD 0 2015-01-01 2015-12-31 2015 FY 10-K 2016-03-11 0001140361-16-057505
us-gaap ValuationAllowanceDeferredTaxAssetChangeInAmount Valuation Allowance, Deferred Tax Asset, Increase (Decrease), Amount USD 3.30M 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-12 0001193125-26-104258
us-gaap WarrantsAndRightsOutstanding Warrants and Rights Outstanding USD 1,000 2021-12-31 2022 FY 10-K 2023-02-23 0000950170-23-004099
us-gaap WeightedAverageNumberOfDilutedSharesOutstanding Weighted Average Number of Shares Outstanding, Diluted shares 7.04M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-13 0001193125-26-460950
us-gaap WeightedAverageNumberOfShareOutstandingBasicAndDiluted Weighted Average Number of Shares Outstanding, Basic and Diluted shares 21.51M 2022-01-01 2022-03-31 2022 Q1 10-Q 2022-04-21 0001564590-22-015075
us-gaap WeightedAverageNumberOfSharesOutstandingBasic Weighted Average Number of Shares Outstanding, Basic shares 7.04M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-13 0001193125-26-460950

Financialist News Desk

Our desk turns official SEC filings into news. Each story is checked against the original filing. About us → · Editorial standards →